Telomerase RNA component knockout exacerbates Staphylococcus aureus pneumonia by extensive inflammation and dysfunction of T cells Authors: Yasmina Reisser, Franziska Hornung, Antje Häder, Thurid Lauf, Sandor Nietzsche, Bettina Löffler, Stefanie Deinhardt-Emmer, Urszula Krzych, Yasmina Reisser, Franziska Hornung, Antje Haeder, Thurid Lauf, Sandor Nietzsche, Bettina Löffler, Stefanie Deinhardt-Emmer Published: 2024 ABSTRACT The telomerase RNA component (Terc) constitutes a non-coding RNA critical for telomerase function, commonly associated with aging and pivotal in immunomodulation during inflammation. Our study unveils heightened susceptibility to pneumonia caused by Staphylococcus aureus (S. aureus) in Terc knockout (Tercko/ko) mice compared to both young and old infected counterparts. The exacerbated infection in Tercko/ko mice correlates with heightened inflammation, manifested by elevated interleukin-1β (IL-1β) levels and activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome within the lung. Employing mRNA sequencing methods alongside in vitro analysis of alveolar macrophages (AMs) and T cells, our study elucidates a compelling correlation between Tercko/ko, inflammation, and impaired T cell functionality. Terc deletion results in compromised T cell function, characterized by dysregulation of the T cell receptor and absence of CD247, potentially compromising the host’s capacity to mount an effective immune response against S. aureus. This investigation provides insights into the intricate mechanisms governing increased vulnerability to severe pneumonia in the context of Terc deficiency, which might also contribute to aging-related pathologies, while also highlighting the influence of Terc on T cell function. Introduction As the global population ages, the impact of infectious diseases on the aging population becomes increasingly significant. Among the most relevant risk factors leading to higher susceptibility as well as severity in both community-acquired (CA) and healthcare-associated (HA) pneumonia is advanced age (≥60 years) (Torres et al., 2021). Particularly severe is pneumonia caused by Staphylococcus aureus (S. aureus) (Lee et al., 2022). S. aureus is a gram-positive bacterium that frequently colonizes humans but can manifest various pathologies, ranging from mild to more severe infections, including pneumonia (Howden et al., 2023; Jong et al., 2019). It accounts for a notable proportion of CA and HA cases (Lee et al., 2022; Torres et al., 2021). The bacterium exhibits a broad spectrum of virulence factors, including toxins, adhesins, and immune evasion strategies, contributing to its ability to establish infections in the lower respiratory tract (Howden et al., 2023). Aging is a central factor predisposing individuals to a higher risk for S. aureus pneumonia (Torres et al., 2021), as aging is impacting several important functions of the body such as the immune response and thus the capability to mount an effective defensive response (Montecino-Rodriguez et al., 2013). Aging-related dysregulation of the immune response is also characterized by inflammaging, defined as the presence of elevated levels of pro-inflammatory cytokines in the absence of an obvious inflammatory trigger (Franceschi et al., 2000; Mogilenko et al., 2022). Additionally, immune cells, such as macrophages, exhibit an activated state that alters their response to infection (Canan et al., 2014). In contrast, the immune response of macrophages to infectious challenges has been shown to be initially impaired in aged mice (Boe et al., 2017). Thus aging is a relevant factor impacting the pulmonary immune response. This highlights the vital connection between aging and S. aureus pneumonia, as well as the need for further research investigating this connection. The process of aging is a multifaceted phenomenon that involves various underlying mechanisms, known as hallmarks (López-Otín et al., 2023). Among these hallmarks, telomere shortening is a significant factor in cellular aging. Telomeres serve as protective caps at the end of chromosomes, which shorten with every cell division until they reach a critical length where replication becomes impossible, eventually resulting in either apoptosis or senescence (López-Otín et al., 2023). However, this process can be counteracted by the telomerase, which can add new repeats to the ends of chromosomes and thus prevent the shortening of telomeres (Greider and Blackburn, 1985). The telomerase mainly consists of two parts: the telomerase reverse transcriptase (Tert), which harbors the enzymatic activity, and Terc, which serves as a template for the addition of new repeats (Sahin and Depinho, 2010; Shay and Wright, 2019). Telomerase activity is restricted to specific tissues and cell types, largely dependent on the expression of Tert. While Tert is highly expressed in stem cells, progenitor cells, and germline cells, its expression is minimal in most differentiated cells (Chakravarti et al., 2021). Consequently, the impact of telomerase dysfunction on tissues varies according to their self-renewal rate (Chakravarti et al., 2021). One important aspect of telomere dysfunction is the impact of telomere shortening on the immune system as well as the hematopoietic system. Tissues or organ systems that are highly replicative, such as the skin or the hematopoietic system, are affected first by telomere shortening (Chakravarti et al., 2021). Due to the loss of the protective telomere caps, mutations can accumulate, and the cells ultimately become senescent (Chakravarti et al., 2021). Interestingly, while most differentiated cells do not exhibit telomerase activity, T cells display a high activity of this enzyme (Hodes et al., 2002). Aging T cells become senescent, which is characterized by short telomeres and the absence of CD28 expression (Hohensinner et al., 2011). Furthermore, telomere length and T cell functionality are closely connected. T cells with shorter telomeres are implicated in diseases related to aging like arthritis (Hohensinner et al., 2011). Additionally, CD4+ T cells from Terc knockout (Tercko/ko) mice displayed several characteristics of aged T cells such as a reduction in CD28 expression and changed secretion of cytokines. Furthermore the naïve T cell population was found to be reduced (Matthe et al., 2022). This highlights the importance of intact telomeres and telomerase on immune cell function. While most differentiated cells lack the expression of Tert, almost all human cells and several murine tissues express Terc (Zhang et al., 2018). However, the function of ubiquitous Terc expression remains elusive (Chakravarti et al., 2021; Shay and Wright, 2019). Interestingly, recent studies identified a variety of functions of Terc, which are independent of its function as part of the telomerase. Notably, a study could show that Terc triggers inflammation via the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway (Liu et al., 2019). Furthermore, Terc was identified to be involved in cell proliferation by enhancing the expression of several genes belonging to the phosphoinositide 3-kinase (Pi3K)-protein kinase B (AKT) pathway (Wu et al., 2022). The same study could show that this mechanism also contributed to CD4+ T cell expansion (Wu et al., 2022). Additionally, Terc deletion in mice induced NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in macrophages upon pulmonary infection with S. aureus, thereby revealing another connection between immune modulation and the presence of Terc (Kang et al., 2018). Thus, it appears that Terc could serve as a relevant immunomodulatory factor, potentially implicated in S. aureus - induced pathologies. Interestingly, downregulation of Terc and Tert expression in tissues of aged mice and rats has been found (Tarry-Adkins et al., 2021; Zhang et al., 2018). Therefore, as a potential immunomodulatory factor reduced Terc expression could be connected to aging-related pathologies. Knockout of Terc in mice is a well-established model for premature aging, as telomeres of Tercko/ko mice shorten with every generation (Wong et al., 2009). Additionally, the telomeres shorten during each generation with increasing age of the mice (Wong et al., 2009). Furthermore, third-generation (G3) Tercko/ko mice with a C56Bl/6 background have a shorter lifespan, a smaller litter size, and a generally reduced body size and weight (Wong et al., 2009). Although G3 Tercko/ko mice with shortened telomeres were used in this study, they were infected at a young age (8 weeks). This approach allowed for the investigation of Terc deletion effects rather than telomere dysfunction. As control cohort age-matched young WT mice were utilized. To investigate whether Terc deletion, beyond critical telomere shortening, impacts the pulmonary immune response, we used young Tercko/ko mice. Additionally, naturally aged mice (2 years of age) were infected to explore the potential link to a fully developed aging phenotype. In this study, we aimed to investigate the impact of Terc deletion, as an essential immunomodulatory factor, on the immune response to S. aureus - induced pneumonia in mice. For this purpose, G3 Tercko/ko mice were infected with S. aureus, and the progression of disease and immune response were evaluated. Strikingly, our data highlights that the deletion of Terc resulted in a more severe disease outcome and disrupted the innate and adaptive immune response. These findings suggest a possible connection between Terc and immune cell homeostasis. Results Terc knockout is associated with severe pneumonia in mice To investigate the impact of Terc on the course of S. aureus pneumonia, we compared young Tercko/ko mice to young and old wild-type (WT) mice. For this purpose, we performed an intranasal infection of Tercko/ko mice at the age of 8 weeks and naturally aged mice at the age of 2 years (old WT) with the S. aureus strain USA300. WT mice at the age of 8 weeks (young WT) were additionally infected and utilized as the control group (Figure 1A). Tercko/ko mice exhibit more severe pneumonia with increased mortality and a higher bacterial load. (A) Clinical score of non-infected and infected young wild-type (WT) (n=10, 5 non-infected and 5 infected), old WT (n=10, 5 non-infected and 5 infected), and Tercko/ko (n=8, 3 non-infected and 5 infected) mice at 24 hr post infection (hpi). The age and genetic background of the different groups is depicted below. (B) Bacterial load of the lungs of infected mice at 24 hpi. Data is displayed as logarithmic. (C) Relative body weight of young WT, old WT, and Tercko/ko mice. Relative body weight displays body weight at 24 hpi as a percentage of the body weight at the time of infection. (D) Relative lung weight of young WT, old WT, and Tercko/ko mice. Relative lung weight displays lung weight at 24 hpi as a percentage of the current body weight. (E) Immunofluorescence staining of lung tissue of infected young (WT 8 weeks), old (WT 2 years), and Tercko/ko mice. Lungs were stained for S. aureus (green), actin (red), and DAPI (blue). Representative pictures are shown for each group. *p<0.05, **p<0.01, ***p<0.001. p-Values calculated by Kruskal-Wallis test (A–D). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. Each replicate is displayed as a data point. Created with BioRender.com. Figure 1—source data 1.Numeric mice data for Figure 1A–D and Figure 1—figure supplement 1A–E. Numeric mice data for Figure 1A–D and Figure 1—figure supplement 1A–E. Figure 1—figure supplement 1.Tercko/ko mice with systemic infection display more severe pneumonia with bacteremia and increased mortality.(A) Clinical score of infected Tercko/ko mice at the time of infection (0 dpi) and 24 hr post infection (hpi) (1 dpi). The mice were divided into three groups according to their clinical score values: mice with mild infection (dark blue dots; n=1), mice with systemic infection (light blue dots; n=2), and mice where infection resulted in a fatal outcome (black dots; n=2). Mice with systemic infection were defined as mice with an increased clinical score and the presence of bacteria in organs other the lung. (B) Bacterial load in kidney and liver tissue of the infected Tercko/ko mice 24 hpi (each n=3). Light blue data points represent mice with systemic infection, while dark blue dots represent the mouse with mild infection. (C) Bacterial load of the lung of infected mice at 24 hpi. Young wild-type (WT) and old WT mice: n=5; Tercko/ko mice with systemic infection: n=2, Tercko/ko mice without systemic infection: n=1. Data is displayed as logarithmic. (D) Relative body weight of young WT (each n=5), old WT (each n=5), and Tercko/ko mice (non-infected: n=3; with systemic infection: n=2; without systemic infection: n=1). Relative body weight displays body weight at 24 hpi as a percentage of the body weight at the time of infection. (E) Relative lung weight of young WT (each n=5), old WT (each n=5), and Tercko/ko mice (non-infected: n=3; with systemic infection: n=2; without systemic infection: n=1). Relative lung weight displays lung weight after 24 hpi as a percentage of the current body weight. (F) Measurement of average telomere length per chromosome end in lungs of young WT (n=4), old WT (n=4), and Tercko/ko mice (n=4). (G) Principal component analysis (PCA) of sequenced lungs from non-infected and infected young WT (each n=3), old WT (each n=3), and Tercko/ko mice (each n=3). The mice with systemic infection clustered separately from the other samples. Nevertheless, the infected Tercko/ko mice were considered one group for the expression analysis and not split into separate groups for the subsequent analysis. (H) Number of differentially expressed genes (DEGs) per comparison including up- and downregulated DEGs as well as the total count. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Sequencing data displays mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hpi. For each mouse cohort three biological replicates were sequenced and used for analysis. Infected Tercko/ko mice were divided into systemic and non-systemic infected mice for several analyses (C, D, and E). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. *p<0.05. p-Values calculated by Kruskal-Wallis test (C–E). Each replicate is displayed as a data point. Figure 1—figure supplement 1—source data 1.Numeric data for Figure 1—figure supplement 1F. Figure 1—figure supplement 1—source data 2.Numeric data for Figure 1—figure supplement 1H. Tercko/ko mice with systemic infection display more severe pneumonia with bacteremia and increased mortality. (A) Clinical score of infected Tercko/ko mice at the time of infection (0 dpi) and 24 hr post infection (hpi) (1 dpi). The mice were divided into three groups according to their clinical score values: mice with mild infection (dark blue dots; n=1), mice with systemic infection (light blue dots; n=2), and mice where infection resulted in a fatal outcome (black dots; n=2). Mice with systemic infection were defined as mice with an increased clinical score and the presence of bacteria in organs other the lung. (B) Bacterial load in kidney and liver tissue of the infected Tercko/ko mice 24 hpi (each n=3). Light blue data points represent mice with systemic infection, while dark blue dots represent the mouse with mild infection. (C) Bacterial load of the lung of infected mice at 24 hpi. Young wild-type (WT) and old WT mice: n=5; Tercko/ko mice with systemic infection: n=2, Tercko/ko mice without systemic infection: n=1. Data is displayed as logarithmic. (D) Relative body weight of young WT (each n=5), old WT (each n=5), and Tercko/ko mice (non-infected: n=3; with systemic infection: n=2; without systemic infection: n=1). Relative body weight displays body weight at 24 hpi as a percentage of the body weight at the time of infection. (E) Relative lung weight of young WT (each n=5), old WT (each n=5), and Tercko/ko mice (non-infected: n=3; with systemic infection: n=2; without systemic infection: n=1). Relative lung weight displays lung weight after 24 hpi as a percentage of the current body weight. (F) Measurement of average telomere length per chromosome end in lungs of young WT (n=4), old WT (n=4), and Tercko/ko mice (n=4). (G) Principal component analysis (PCA) of sequenced lungs from non-infected and infected young WT (each n=3), old WT (each n=3), and Tercko/ko mice (each n=3). The mice with systemic infection clustered separately from the other samples. Nevertheless, the infected Tercko/ko mice were considered one group for the expression analysis and not split into separate groups for the subsequent analysis. (H) Number of differentially expressed genes (DEGs) per comparison including up- and downregulated DEGs as well as the total count. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Sequencing data displays mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hpi. For each mouse cohort three biological replicates were sequenced and used for analysis. Infected Tercko/ko mice were divided into systemic and non-systemic infected mice for several analyses (C, D, and E). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. *p<0.05. p-Values calculated by Kruskal-Wallis test (C–E). Each replicate is displayed as a data point. Figure 1—figure supplement 1—source data 1.Numeric data for Figure 1—figure supplement 1F. Numeric data for Figure 1—figure supplement 1F. Figure 1—figure supplement 1—source data 2.Numeric data for Figure 1—figure supplement 1H. Numeric data for Figure 1—figure supplement 1H. The clinical score of infected Tercko/ko mice was increased compared to the other two infected mice cohorts at 24 hr post infection (hpi) (Figure 1A). The bacterial load was significantly higher in the bronchoalveolar lavage (BAL) of Tercko/ko mice compared to old WT mice (Figure 1B). Interestingly, three distinct degrees of severity were observed in the infected Tercko/ko mice (n=5): mild infection, systemic infections, or fatal infections (Figure 1—figure supplement 1A). Mice exhibiting systemic infection were characterized by the presence of bacteria in extrapulmonary organs, specifically observed in the liver and kidney tissues of some Tercko/ko mice (Figure 1—figure supplement 1B). Infection of young WT mice resulted in a significant decrease in body weight at 24 hpi. The body weight of infected Tercko/ko mice was reduced compared to the infected old WT mice and the non-infected Tercko/ko mice (Figure 1C). In contrast, at 24 hpi the relative weight of the lung was increased in infected compared to the non-infected mice for all cohorts, indicating inflammation of the lung (Figure 1D). However, this effect was the most pronounced in young WT mice. Based on our observation of the different degrees of severity displayed by the infected Tercko/ko mice, we categorized them according to their clinical score and the presence of bacteria in extrapulmonary organs, distinguishing between mice with and without systemic infection. This grouping resulted in more pronounced differences between the mice cohorts regarding bacterial load and reduction of relative body weight (Figure 1—figure supplement 1C and D). The relative lung weight increased for all groups compared to the respective non-infected mice, except for the Tercko/ko mouse without systemic infection (Figure 1—figure supplement 1E). Additionally, average telomere length of the lungs of young and old WT as well as Tercko/ko mice was measured. As shortened telomeres are a hallmark of aging, impacting other cellular mechanisms such as cellular senescence, they could have an influence on the disease progression (López-Otín et al., 2023). Notably, the telomeres of Tercko/ko mice were the shortest among the three different mouse models, even shorter than those of naturally aged mice (Figure 1—figure supplement 1F). In order to investigate gene expression patterns, mRNA sequencing of the lungs was performed. This data supported the grouping of infected Tercko/ko mice into different groups, as the principal component analysis plot showed a separate cluster containing Tercko/ko mice with systemic infection (Figure 1—figure supplement 1G). Immunofluorescence (IF) staining of S. aureus within the lung tissue of all three infected mice cohorts was carried out. The increased signal for S. aureus in sections of Tercko/ko mice compared to sections of young WT and old WT mice closely reflects the quantified colony-forming units (CFU) detected in the BAL (Figure 1E). Tercko/ko mice were characterized by an increased bacterial load in the lungs, a higher clinical score, as well as mortality (Figure 1A and B; Figure 1—figure supplement 1A). Additionally, we could observe different degrees of severity in the infected Tercko/ko cohort and could identify a subgroup of mice with systemic infection (Figure 1—figure supplement 1A, B, and G). Tercko/ko mice showed excessive inflammation with inflammasome activation In order to investigate the underlying pathomechanisms leading to a more severe course of disease in the Tercko/ko mice, inflammation parameters in the lungs were measured. In the course of this analysis, we applied the previously outlined groups of mice, differentiating between those with and without systemic infection in the Tercko/ko cohort. Several pro-inflammatory cytokines were significantly upregulated in Tercko/ko mice with systemic infection, such as interleukin-6 (IL-6), granulocyte-macrophage colony-stimulating factor, and interleukin-1β (IL-1β). Other important pro-inflammatory factors like tumor necrosis factor α (TNFα) and interleukin-1α (IL-1α) were also elevated (Figure 2A). A significant upregulation of pro-inflammatory mediators due to infection was, however, solely detected in infected Tercko/ko mice compared to the corresponding non-infected control cohort (Figure 2A). Lungs of Tercko/ko mice display excessive inflammation and NLRP3 inflammasome activation. (A) Pro-inflammatory cytokines measured in lung homogenates of non-infected and infected young wild-type (WT) (each n=3), old WT (each n=5), and Tercko/ko mice (non-infected: n=3, with systemic infection: n=2, and without systemic infection: n=1). Infected Tercko/ko mice were grouped into mice with systemic and without systemic infection. Cytokines were measured using a flow cytometry-based LEGENDPlex mouse inflammation panel. Data is displayed on a logarithmic scale. (B) Heatmap of overall gene expression in the lungs of the different mice cohorts at 24 hr post infection (hpi). Gene expression is displayed as the log2 of the fragments per kilobase of transcript per million fragments mapped (fpkm) of each individual gene. Gene expression is normalized to sequencing depth and transcript length. Red indicates upregulation, and green indicates downregulation of the gene expression. The respective mouse groups are visualized above the heatmap. For each mouse cohort three biological replicates were sequenced. (C) Heatmap of differentially expressed genes (DEGs) belonging to the NLRP3 inflammasome pathway. Red indicates upregulation, and blue indicates downregulation of the gene. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Heatmaps were constructed using RStudio. Only significant DEGs (p-value<0.05) were displayed in the heatmap. Non-significant genes were set to zero and are shown as white. DEGs are displayed as log2fold-change. For each group three biological replicates were sequenced and used for analysis. For clarity, the heatmap has been split in half, and no column clustering has been performed. The respective groups used for the comparison are indicated below each column. (D) KEGG pathway enrichment analysis comparing infected young and Tercko/ko mice at 24 hpi. The gene ratio describes the ratio of differentially expressed genes to all genes of the respective pathway. The dot plot was constructed using RStudio. All sequencing data displays mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hpi. ns≥0.05, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. p-Values calculated by Kruskal-Wallis test (A). Data is presented as mean ± SD. Each replicate is displayed as a data point. Figure 2—source code 1.R code for heatmap construction.Source Code 1 was used for the construction of all following heatmaps. Labels, title, Source Data file, and number of columns in Source Data file were adjusted for each heatmap. R code for heatmap construction. Source Code 1 was used for the construction of all following heatmaps. Labels, title, Source Data file, and number of columns in Source Data file were adjusted for each heatmap. Figure 2—source code 2.R code for KEGG enrichment analysis dot plot construction.Source Code 2 was used for all following KEGG enrichment analysis dot plot construction. Title and Source Data file were adjusted for each KEGG dot plot. R code for KEGG enrichment analysis dot plot construction. Source Code 2 was used for all following KEGG enrichment analysis dot plot construction. Title and Source Data file were adjusted for each KEGG dot plot. Figure 2—source data 1.Numeric data for Figure 2A.Table of cytokine concentrations measured. Numeric data for Figure 2A. Table of cytokine concentrations measured. Figure 2—source data 2.Numeric data for Figure 2B.Table of fragments per kilobase of transcript per million fragments mapped (fpkms) for all genes measured across the different mice cohorts. Numeric data for Figure 2B. Table of fragments per kilobase of transcript per million fragments mapped (fpkms) for all genes measured across the different mice cohorts. Figure 2—source data 3.Numeric data for Figure 2C.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 2C. List of relevant differentially expressed genes (DEGs). Figure 2—source data 4.Numeric data for Figure 2D.List of relevant significantly enriched KEGG pathways. Numeric data for Figure 2D. List of relevant significantly enriched KEGG pathways. Figure 2—figure supplement 1.Several pathways relevant for inflammation and adaptive and innate immune response are differentially expressed in infected Tercko/ko mice.Heatmaps of differentially expressed genes (DEGs) related to the NLRP3 inflammasome pathway (A), macrophage marker (C), chemokine signaling pathway (D), T helper cell marker (E), or T cell receptor (TCR) signaling (F). Red indicates upregulation, and blue indicates downregulation of the gene. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Heatmaps were constructed using RStudio. Only significant DEGs (p-value<0.05) were displayed in the heatmap. Non-significant genes were set to zero and are shown as white. DEGs are displayed as log2fold-change. For each mouse cohort three biological replicates were sequenced and used for analysis. The respective groups used for the comparison are indicated below each column. All comparisons are shown. All heatmaps display mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hr post infection (hpi). (B) Immunofluorescence staining of CD68 (red), actin (purple), and DAPI (blue) of alveolar macrophages (AMs) isolated from Tercko/ko and young wild-type (WT) mice. Representative pictures are shown for each group. Figure 2—figure supplement 1—source data 1.Numeric data for Figure 2—figure supplement 1A.List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 2.Numeric data for Figure 2—figure supplement 1C.List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 3.Numeric data for Figure 2—figure supplement 1D.List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 4.Numeric data for Figure 2—figure supplement 1E.List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 5.Numeric data for Figure 2—figure supplement 1F.List of relevant differentially expressed genes (DEGs). Several pathways relevant for inflammation and adaptive and innate immune response are differentially expressed in infected Tercko/ko mice. Heatmaps of differentially expressed genes (DEGs) related to the NLRP3 inflammasome pathway (A), macrophage marker (C), chemokine signaling pathway (D), T helper cell marker (E), or T cell receptor (TCR) signaling (F). Red indicates upregulation, and blue indicates downregulation of the gene. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Heatmaps were constructed using RStudio. Only significant DEGs (p-value<0.05) were displayed in the heatmap. Non-significant genes were set to zero and are shown as white. DEGs are displayed as log2fold-change. For each mouse cohort three biological replicates were sequenced and used for analysis. The respective groups used for the comparison are indicated below each column. All comparisons are shown. All heatmaps display mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hr post infection (hpi). (B) Immunofluorescence staining of CD68 (red), actin (purple), and DAPI (blue) of alveolar macrophages (AMs) isolated from Tercko/ko and young wild-type (WT) mice. Representative pictures are shown for each group. Figure 2—figure supplement 1—source data 1.Numeric data for Figure 2—figure supplement 1A.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 2—figure supplement 1A. List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 2.Numeric data for Figure 2—figure supplement 1C.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 2—figure supplement 1C. List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 3.Numeric data for Figure 2—figure supplement 1D.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 2—figure supplement 1D. List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 4.Numeric data for Figure 2—figure supplement 1E.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 2—figure supplement 1E. List of relevant differentially expressed genes (DEGs). Figure 2—figure supplement 1—source data 5.Numeric data for Figure 2—figure supplement 1F.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 2—figure supplement 1F. List of relevant differentially expressed genes (DEGs). We performed mRNA sequencing of the murine lung tissue of infected and non-infected mice at 24 hpi to elucidate potential differentially expressed genes (DEGs) that contribute to the more severe illness of Tercko/ko mice. Comparison of overall gene expression pattern of the different groups revealed that non-infected young WT and Tercko/ko mice cluster together and show a similar expression pattern. In contrast, the infected mice of those cohorts display different expression patterns (Figure 2B). This highlights that most differences between the knockout and WT mice are only present after infection with S. aureus. Furthermore, both non-infected and infected old WT mice show a completely distinct expression profile compared to young WT as well as Tercko/ko mice (Figure 2B). Intriguingly, several genes related to the NLRP3 inflammasome pathway, such as NLRP3 or thioredoxin interacting protein (TXNIP), were upregulated in infected Tercko/ko, indicating activation of the inflammasome (Figure 2C; Figure 2—figure supplement 1A). Notably, expression of genes encoding for TNFα, IL-1β, and IL-6 were heightened. Thus, the increased inflammation in the lungs of Tercko/ko mice is likely induced by activation of the NLRP3 inflammasome (Figure 2C; Figure 2—figure supplement 1A). Supporting this, the nucleotide oligomerization domain-like receptor signaling pathway was among the most significantly enriched pathways when comparing infected Tercko/ko and young WT mice (Figure 2D). Macrophages are part of the first line of defense against bacterial infections as they can phagocytose bacteria and support pathogen clearance. Alveolar macrophages (AMs) are present in the lung and can directly react to the pathogen at the site of infection via the production of inflammatory mediators or attraction of other immune cells (Malainou et al., 2023). To specifically investigate the role of AMs during S. aureus infection, we isolated them from lungs of young WT and Tercko/ko mice. By using scanning electron microscopy (SEM) we could strikingly visualize the ability of AMs to phagocytose S. aureus (Figure 3A). Additionally, we identified the AMs via IF staining of the macrophage marker CD68 (Figure 2—figure supplement 1B). Elevated expression of pro-inflammatory M1 macrophages markers and chemokines are present in the lungs of infected Tercko/ko mice. (A) Colorized scanning electron microscopy (SEM) picture of an alveolar macrophage (AM) isolated from young wild-type (WT) mice phagocytosing S. aureus. Heatmap of differentially expressed macrophage markers (B) and differentially expressed genes (DEGs) belonging to the chemokine signaling pathway (C). Red indicates upregulation, and blue indicates downregulation of the gene. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Heatmaps were constructed using RStudio. Only significant DEGs (p-value<0.05) were displayed in the heatmap. Non-significant genes were set to zero and are shown as white. DEGs are displayed as log2fold-change. For each group three biological replicates were sequenced and used for analysis. The respective groups used for the comparison are indicated below each column. All heatmaps display mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hr post infection (hpi). Figure 3—source data 1.Numeric data for Figure 3B.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 3B. List of relevant differentially expressed genes (DEGs). Figure 3—source data 2.Numeric data for Figure 3C.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 3C. List of relevant differentially expressed genes (DEGs). Notably, our sequencing data revealed an upregulation of pro-inflammatory M1 macrophage markers, such as C-X-C motif chemokine ligand 2(CXCL2), in Tercko/ko mice following infection (Figure 3B; Figure 2—figure supplement 1C). Anti-inflammatory M2 markers, e.g., interferon regulatory factor 4 (IRF4), were mainly downregulated. Additionally, cluster of differentiation 14 (CD14), a general macrophage marker, was increased in the infected Tercko/ko mice (Figure 3B; Figure 2—figure supplement 1C). Furthermore, the expression of multiple chemokines such as C-X-C motif ligand 1–3 (CXCL1-3) and C-C motif chemokine ligand 2 (CCL2) was elevated, suggesting increased migration of leukocytes such as macrophages and neutrophils to the lung (Figure 3C; Figure 2—figure supplement 1D). Additionally, the TNF, NF-κB, and IL-17 signaling pathways were among the most significantly enriched pathways in infected Tercko/ko mice compared to young WT mice (Figure 2D). Combining the findings above, S. aureus infection in Tercko/ko mice leads to excessive inflammation induced by NLRP3 inflammasome activation and infiltration of pro-inflammatory immune cells, such as M1 macrophages. The T cell receptor is partially downregulated in infected Tercko/ko mice In addition to macrophages, T cells and their activation play a crucial role in the immune response and are vital for resolving infections. Surprisingly, multiple general T cell markers such as CD2, CD5, and CD4 were downregulated in the infected Tercko/ko mice compared to young WT mice (Figure 4A; Figure 2—figure supplement 1E). However, these distinctions are not evident in comparisons between non-infected Tercko/ko and young WT mice. This further emphasizes that the observed variations in immune response activation arise specifically in response to infection (Figure 4A). Some T cell markers, such as CD5, that were downregulated in infected Tercko/ko mice were also downregulated in infected old WT mice compared to young WT mice (Figure 2—figure supplement 1E). T cell receptor (TCR) in infected Tercko/ko mice is partially downregulated. Heatmap of differentially expressed T helper cell markers (A) and differentially expressed genes (DEGs) belonging to the TCR signaling pathway (C). Red indicates upregulation, and blue indicates downregulation of the gene. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Heatmaps were constructed using RStudio. Only significant DEGs (p-value<0.05) were displayed in the heatmap. Non-significant genes were set to zero and are shown as white. DEGs are displayed as log2fold-change. For each mouse cohort three biological replicates were sequenced and used for analysis. The respective groups used for the comparison are indicated below each column. All heatmaps display mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hr post infection (hpi). (B) Percentage of CD3+-living cells in non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5) spleen. Cells were analyzed with flow cytometry. Gene expression levels in fragments per kilobase of transcript per million fragments mapped (fpkm) of CD247 (D), PDCD1 (E), and CD4 (F) in the lungs of non-infected and infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=3) at 24 hpi. ns≥0.05, *p<0.05, **p<0.01. p-Values calculated by Kruskal-Wallis test (B, D–F). Data is displayed as violin or box plot showing the median as well as lower and upper percentile of each dataset. Each replicate is displayed as a data point. Figure 4—source data 1.Numeric data for Figure 4A.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 4A. List of relevant differentially expressed genes (DEGs). Figure 4—source data 2.Numeric data for Figure 4B.Percentages of live CD3+ cells. Numeric data for Figure 4B. Percentages of live CD3+ cells. Figure 4—source data 3.Numeric data for Figure 4C.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 4C. List of relevant differentially expressed genes (DEGs). Figure 4—source data 4.Numeric data for Figure 4D–F.Fragments per kilobase of transcript per million fragments mapped (fpkms) of the different mice cohorts for CD247, PDCD1, and CD4. Numeric data for Figure 4D–F. Fragments per kilobase of transcript per million fragments mapped (fpkms) of the different mice cohorts for CD247, PDCD1, and CD4. Figure 4—source data 5.List of all fragments per kilobase of transcript per million fragments mapped (fpkms) for each individual mouse sequenced. List of all fragments per kilobase of transcript per million fragments mapped (fpkms) for each individual mouse sequenced. Figure 4—figure supplement 1.Frequency of different immune cell populations in the spleen of young and old WT as well as Tercko/ko mice.(A) Exemplary gating strategy for the immunophenotyping of cells from murine spleen. First, lymphocytes were selected, then duplicates and dead cells were excluded (APC-Cy7 negative). To avoid autofluorescence of macrophages, the F4/80 negative population was selected. For further calculations of T cell frequencies the CD3+ CD19- cell population was used. Other immune cell populations were selected by the indicated marker. For calculation of macrophage frequencies the F4/80 positive population was selected. (B) Percentage of Ly-6G+-living cells in the spleen of non-infected young wild-type (WT) (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (C) Percentage of CD19+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (D) Percentage of CD335+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (E) Percentage of F4/80+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (F) Percentage of CD11c+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. ns≥0.05, *p<0.05, **p<0.01. p-Values calculated by Kruskal-Wallis test (B–F). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. Each replicate is displayed as a data point. Figure 4—figure supplement 1—source data 1.Numeric data for Figure 4—figure supplement 1B–F. Frequency of different immune cell populations in the spleen of young and old WT as well as Tercko/ko mice. (A) Exemplary gating strategy for the immunophenotyping of cells from murine spleen. First, lymphocytes were selected, then duplicates and dead cells were excluded (APC-Cy7 negative). To avoid autofluorescence of macrophages, the F4/80 negative population was selected. For further calculations of T cell frequencies the CD3+ CD19- cell population was used. Other immune cell populations were selected by the indicated marker. For calculation of macrophage frequencies the F4/80 positive population was selected. (B) Percentage of Ly-6G+-living cells in the spleen of non-infected young wild-type (WT) (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (C) Percentage of CD19+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (D) Percentage of CD335+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (E) Percentage of F4/80+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. (F) Percentage of CD11c+-living cells in the spleen of non-infected young WT (n=3), old WT (n=3), and Tercko/ko mice (n=5). Cells were analyzed with flow cytometry. ns≥0.05, *p<0.05, **p<0.01. p-Values calculated by Kruskal-Wallis test (B–F). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. Each replicate is displayed as a data point. Figure 4—figure supplement 1—source data 1.Numeric data for Figure 4—figure supplement 1B–F. Numeric data for Figure 4—figure supplement 1B–F. To rule out that this effect is caused by a reduction of T cells in Tercko/ko mice, the immune cells of non-infected Tercko/ko, young WT and old WT mice were analyzed via flow cytometry. However, no significant difference was observed between the groups (Figure 4B). Additionally, several genes belonging to the T cell receptor (TCR) signaling pathway were downregulated in infected Tercko/ko mice, such as CD3G (encoding CD3γ) and CD247 encoding CD3ζ (Figure 4C, Figure 2—figure supplement 1F). Expression of downstream factors of the TCR like lymphocyte cell-specific protein-tyrosine kinase (LCK), linker of activation (LAT), and IL-2 inducible T cell kinase (ITK) was also reduced (Figure 4C, Figure 2—figure supplement 1F). We also noted several of these distinctions, including the downregulation of LCK and ITK when comparing infected old WT and young WT mice (Figure 4C). Since there was no reduction of T cells in Tercko/ko mice, the change in TCR signaling and marker expression is likely induced by the infection. Specifically, CD247 was the only gene downregulated compared to infected young WT, old WT, and non-infected Tercko/ko mice (Figure 4C). Additionally, CD247 was downregulated in infected old WT mice compared to infected young WT mice (Figure 4C). CD247 is an essential factor for the assembly of the TCR and the downstream signaling after stimulation with an antigen (Jin et al., 2024; Pitcher et al., 2003). In young WT mice gene expression levels of CD247 were increased with infection, likely due to proliferation and infiltration of T cells (Figure 4D). Notably, in infected Tercko/ko mice, the expression of CD247 is absent. Moreover, there is no difference in CD247 expression between non-infected and infected old WT mice (Figure 4D). Similar trends can be seen for other T cell markers, such as programmed cell death 1 (PDCD1) and CD4 (Figure 4E and F). Additionally, the TCR signaling pathway and Th1 and Th2 differentiation pathway are among the most enriched pathways in infected young WT mice compared to non-infected young WT mice. In contrast, those pathways are not upregulated when comparing infected Tercko/ko with non-infected Tercko/ko mice (Figure 5—figure supplement 1A). These findings indicate a malfunction in the activation of T cells as components of the TCR signaling pathway were partially downregulated. The complete absence of CD247, an essential factor for downstream activation of the TCR, indicates aberrant T cell function of Tercko/ko mice during infection. T cells of Tercko/ko mice do not adequately react to infectious challenge To investigate the functionality of T cells and their CD247 expression in Tercko/ko mice during infection, murine T cells and AMs were isolated. An overactive inflammatory response could be a potential explanation for the dysregulated TCR signaling. Therefore, to study the impact of AMs on T cells we infected the co-culture of both isolated cells with a multiplicity of infection 5 (MOI5) of heat-killed (HK) S. aureus for 24 hr (Figure 5A). All components of the experimental setup were visualized using SEM. In particular, the close association between AMs and T cells was notable (Figure 5B). IF staining of AMs of Tercko/ko and young WT mice revealed the successful internalization of S. aureus as well as a change of phenotypic appearance to a more activated shape (Figure 5C). T cells of Tercko/ko mice do not adequately react to bacterial challenge. (A) Schematic representation of experiment. Murine T cells and alveolar macrophages (AMs) were isolated, co-cultured, and stimulated with heat-killed S. aureus with a multiplicity of infection 5 (MOI5) for 24 hr. (B) Colorized scanning electron microscopy (SEM) picture of the experimental setup. An AM close to a T cell is shown. (C) Immunofluorescence staining of infected and non-infected AMs from young wild-type (WT) and Tercko/ko mice. AMs were stained with antibodies for S. aureus (red), actin (purple), and DAPI (blue). (D) CD247 expression measured with flow cytometry of non-infected and infected T cells (left) and co-cultured T cells and AMs (right) of young WT (each n=3) and Tercko/ko mice (each n=3) after 24 hr post infection (hpi). CD247 expression is displayed as geometric mean fluorescence intensity (gMFI). (E) Interleukin-1α (IL-1α) from supernatants of T cells (left) and co-cultured T cells and AMs (right) of young WT (each n=3) and Tercko/ko mice (each n=3) at 2 and 24 hpi. IL-1α levels were measured using a flow cytometry-based LEGENDPlex mouse T helper cytokine panel. ns≥0.05, *p<0.05. p-Values calculated by Kruskal-Wallis test (D, E). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. Each replicate is displayed as a data point. Created with BioRender.com. Figure 5—source data 1.Numeric data for Figure 5D.One replicate of the group young wild-type (WT) T cell+alveolar macrophage (AM)+ S. aureus had to be excluded due to a staining error for the displayed surface marker. Numeric data for Figure 5D. One replicate of the group young wild-type (WT) T cell+alveolar macrophage (AM)+ S. aureus had to be excluded due to a staining error for the displayed surface marker. Figure 5—source data 2.Numeric data for Figure 5E. Numeric data for Figure 5E. Figure 5—figure supplement 1.Altered immune response to infection of Tercko/ko mice relative to control cohorts.(A) KEGG pathway enrichment analysis comparing infected Tercko/ko vs. infected old wild-type (WT), infected young WT vs. non-infected young WT, and infected Tercko/ko vs. non-infected Tercko/ko mice. The gene ratio describes the ratio of differentially expressed genes to all genes of the respective pathway. The dot plots were constructed using RStudio. (B) Gating strategy for T cells isolated from murine spleen to asses CD247 expression. First, lymphocytes were selected, duplicates and dead cells were excluded before selecting CD3+ CD247+ cells. This population was used for further calculations. (C) CD44 expression measured with flow cytometry of non-infected and infected T cells (left) and co-cultured T cells and alveolar macrophages (AMs) (right) of young WT (each n=3) and Tercko/ko mice (each n=3) after 24 hr post infection (hpi). CD44 expression is displayed as geometric mean fluorescence intensity (gMFI). (D) Heatmap of differentially regulated myeloid suppressor cell (MSC) markers. Red indicates upregulation, and blue indicates downregulation of the gene. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Heatmaps were constructed using RStudio. Only significant differentially expressed genes (DEGs) (p-value<0.05) were displayed in the heatmap. Non-significant genes were set to zero and are shown as white. DEGs are displayed as log2fold-change. For each mouse cohort three biological replicates were sequenced and used for analysis. The respective groups used for the comparison are indicated below each column. All heatmaps display mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hpi. ns≥0.05. p-Values calculated by Kruskal-Wallis test (C). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. Each replicate is displayed as a data point. Figure 5—figure supplement 1—source data 1.Numeric data for Figure 5—figure supplement 1A.List of significantly enriched KEGG pathways of Tercko/ko S. aureus vs. old wild-type (WT) S. aureus. Figure 5—figure supplement 1—source data 2.Numeric data for Figure 5—figure supplement 1A.List of significantly enriched KEGG pathways of young wild-type (WT) S. aureus vs. young WT mock. Figure 5—figure supplement 1—source data 3.Numeric data for Figure 5—figure supplement 1A.List of significantly enriched KEGG pathways of Tercko/ko S. aureus vs. Tercko/ko mock. Figure 5—figure supplement 1—source data 4.Numeric data for Figure 5—figure supplement 1C. Figure 5—figure supplement 1—source data 5.Numeric data for Figure 5—figure supplement 1D.List of relevant differentially expressed genes (DEGs). Altered immune response to infection of Tercko/ko mice relative to control cohorts. (A) KEGG pathway enrichment analysis comparing infected Tercko/ko vs. infected old wild-type (WT), infected young WT vs. non-infected young WT, and infected Tercko/ko vs. non-infected Tercko/ko mice. The gene ratio describes the ratio of differentially expressed genes to all genes of the respective pathway. The dot plots were constructed using RStudio. (B) Gating strategy for T cells isolated from murine spleen to asses CD247 expression. First, lymphocytes were selected, duplicates and dead cells were excluded before selecting CD3+ CD247+ cells. This population was used for further calculations. (C) CD44 expression measured with flow cytometry of non-infected and infected T cells (left) and co-cultured T cells and alveolar macrophages (AMs) (right) of young WT (each n=3) and Tercko/ko mice (each n=3) after 24 hr post infection (hpi). CD44 expression is displayed as geometric mean fluorescence intensity (gMFI). (D) Heatmap of differentially regulated myeloid suppressor cell (MSC) markers. Red indicates upregulation, and blue indicates downregulation of the gene. Differential gene expression analysis was conducted using the DESeq2 software as well as negative binomial distribution. For false discovery rate (FDR) calculation the Benjamini-Hochberg procedure was used. Heatmaps were constructed using RStudio. Only significant differentially expressed genes (DEGs) (p-value<0.05) were displayed in the heatmap. Non-significant genes were set to zero and are shown as white. DEGs are displayed as log2fold-change. For each mouse cohort three biological replicates were sequenced and used for analysis. The respective groups used for the comparison are indicated below each column. All heatmaps display mRNA sequencing data of non-infected and infected lungs of the three different mice cohorts at 24 hpi. ns≥0.05. p-Values calculated by Kruskal-Wallis test (C). Data is displayed as violin plot showing the median as well as lower and upper percentile of each dataset. Each replicate is displayed as a data point. Figure 5—figure supplement 1—source data 1.Numeric data for Figure 5—figure supplement 1A.List of significantly enriched KEGG pathways of Tercko/ko S. aureus vs. old wild-type (WT) S. aureus. Numeric data for Figure 5—figure supplement 1A. List of significantly enriched KEGG pathways of Tercko/ko S. aureus vs. old wild-type (WT) S. aureus. Figure 5—figure supplement 1—source data 2.Numeric data for Figure 5—figure supplement 1A.List of significantly enriched KEGG pathways of young wild-type (WT) S. aureus vs. young WT mock. Numeric data for Figure 5—figure supplement 1A. List of significantly enriched KEGG pathways of young wild-type (WT) S. aureus vs. young WT mock. Figure 5—figure supplement 1—source data 3.Numeric data for Figure 5—figure supplement 1A.List of significantly enriched KEGG pathways of Tercko/ko S. aureus vs. Tercko/ko mock. Numeric data for Figure 5—figure supplement 1A. List of significantly enriched KEGG pathways of Tercko/ko S. aureus vs. Tercko/ko mock. Figure 5—figure supplement 1—source data 4.Numeric data for Figure 5—figure supplement 1C. Numeric data for Figure 5—figure supplement 1C. Figure 5—figure supplement 1—source data 5.Numeric data for Figure 5—figure supplement 1D.List of relevant differentially expressed genes (DEGs). Numeric data for Figure 5—figure supplement 1D. List of relevant differentially expressed genes (DEGs). Utilizing flow cytometry, we observed a substantial elevation in the baseline expression of CD247 in T cells from Tercko/ko mice in comparison to T cells from young WT mice at 24 hpi (Figure 5D). However, there was no increase in CD247 expression upon stimulation with S. aureus in the Tercko/ko T cells (Figure 5D). In contrast, observation of T cells of young WT mice revealed a tendency toward an increase in CD247 expression in response to S. aureus stimulation (Figure 5D). This indicated improper activation of TCR signaling after S. aureus stimulation in T cells of Tercko/ko mice. We could also detect differences in cytokine production when comparing the AMs and T cells from young WT and Tercko/ko mice. At 24 hpi, IL-1α production was significantly higher in T cells from young WT mice stimulated with S. aureus when compared to the T cells from Tercko/ko mice (Figure 5D, left). Notably, in the co-culture, IL-1α production was significantly higher in Tercko/ko cells 2 hpi (Figure 5D, right). On the contrary, there was a significant induction of IL-1α in the young WT co-culture but no increase in the Tercko/ko co-culture with S. aureus stimulation after 24 hr (Figure 5D, right). Our data indicate that T cells from Tercko/ko mice do not effectively react to the infectious stimulus and thus seem dysfunctional due to TCR downregulation. Discussion Shortening of telomeres is a key factor in the aging process and has a significant impact on other hallmarks of aging, such as mitochondrial dysfunction and cellular senescence (Birch et al., 2018; López-Otín et al., 2023). In this context, the discussion surrounding the importance of Terc is primarily confined to its role within telomerase. Consequently, other potential functions of Terc in various cellular processes have been largely overlooked. Interestingly, various studies have linked Terc to inflammation, as it has been shown to activate the NF-κB and PI3K-AKT pathways (Liu et al., 2019; Wu et al., 2022). Another study could show that the deletion of Terc in mice resulted in NLRP3 inflammasome activation after infection with S. aureus, thus contributing to more severe pneumonia (Kang et al., 2018). These studies suggest a close association between Terc, inflammation, and the response to bacterial lung infections. In our study, we utilized a Tercko/ko S. aureus pneumonia model to investigate this connection. In accordance with German animal welfare regulations and the 3R principle, we only had a reduced number of Tercko/ko mice available for the experiment, as some infections were fatal. This reduced number of mice is a limitation of our study. However, we could demonstrate that Tercko/ko mice presented with a more severe pneumonia, higher bacterial load, and increased mortality compared to old and young WT mice (Figure 1). Additionally, we could show that infected Tercko/ko mice are rather heterogeneous and display several degrees of severity, which we investigated separately. Of five infected mice, two died, two displayed signs of a systemic infection and only one had a mild infection. The mice with systemic infection were grouped based on the presence of bacteria in organs other than the lung, as well as the sequencing data, where they clustered separately. The detection of bacteria in extrapulmonary organs is of particular interest, as bacteremia is a symptom of severe pneumonia and is associated with high mortality (De la Calle et al., 2016). The grouping of Terckoko mice, based on their disease severity, offers the possibility to investigate distinct features of bacterial infection. Tercko/ko mice were previously shown to have higher susceptibility to S. aureus pneumonia, although they exhibited a reduced bacterial load in their lungs (Kang et al., 2018). These differences may be attributed to the missing separation of infected Tercko/ko mice into different degrees of severity. Additionally, this heterogeneity in disease manifestation points toward the limitations of mouse models to study S. aureus pathologies. There are a variety of differences between S. aureus infections in humans and mice. For instance, several relevant virulence factors (e.g. Pantone-Valentine leukocidine) function less efficient in mice than in humans (Zheng et al., 2023). Therefore, higher infection doses are needed to successfully establish an infection that is comparable to humans (Zheng et al., 2023). Inflammation and the activation of the NLRP3 inflammasome are necessary components to fight bacterial infections of the lung. However, excessive inflammation and over-activation of the NLRP3 inflammasome lead to lung injury and can impede pathogen clearance, thus contributing to S. aureus-induced pathologies (McVey et al., 2021; Wang et al., 2022). Upon examining the lungs of infected Tercko/ko mice with systemic infection, we identified a marked increase in inflammation parameters (Figure 2). Furthermore, we discovered that genes associated with the NLRP3 inflammasome pathway were elevated in the infected Tercko/ko mice but not in the corresponding non-infected control cohort. As published previously, this implies that Terc knockout on its own does not result in heightened inflammation and inflammasome activation but rather requires an external trigger (Kang et al., 2018). Inflammasome activation in Tercko/ko mice was connected to mitochondria dysfunction and an elevated reactive oxygen species production. Additionally, regulation of the inflammasome seems to be dysfunctional as TNAIFP3, an important negative regulator of the inflammasome was downregulated in the Tercko/ko mice in this study (Kang et al., 2018). However, we did not observe downregulation of TNFAIP3, but rather an upregulation in infected Tercko/ko mice (Figure 2C). These differences may however be attributed to the different study design. Kang et al. focused on telomere dysfunction studying macrophages of old Tercko/ko mice, while our study investigated the entire lung of young Tercko/ko mice. Of particular note were the heightened levels of IL-1β, a factor known for its ability to amplify the inflammatory response and facilitate the infiltration of pro-inflammatory immune cells, thereby fostering pulmonary injury (Chen et al., 2018; Hu et al., 2020). Additionally, pro-inflammatory macrophages infiltrating the lung are critical to inflammation-mediated lung injury (Chen et al., 2018; Guan et al., 2023). In our study, we could identify the upregulation of several pro-inflammatory macrophage markers in infected Tercko/ko mice, as well as several chemokine markers further exacerbating the inflammation in the lung via attraction of immune cells (Figure 3). Notably, we did not observe upregulation of inflammation parameters or activation of the inflammasome in the infected old WT mice. Although CD14 showed a slight increase in non-infected old WT mice compared to non-infected young WT mice, there was no upregulation of macrophage markers in the infected cohorts of these groups. Innate immune cells of aged individuals especially macrophages are associated with chronic low-grade inflammation contributing to injury during infection (Duong et al., 2021). However, studies could also show that macrophages of aged mice had a reduced response to stimulation of pathogen recognition receptors such as Toll-like receptor 2. This results in an initially diminished and delayed response of macrophages to infectious challenge, which could be a possible explanation for the lack of inflammation at 24 hpi (Boe et al., 2017; Hinojosa et al., 2009). An overactive inflammatory response not only causes tissue damage but also leads to T cell dysfunction (Guan et al., 2023). A possible mechanism is the downregulation of CD247, which is the CD3ζ chain of the TCR. CD247/CD3ζ is necessary for the assembly of the receptor at the cell surface. Furthermore, due to its multiple immunoreceptor tyrosine-based activation motifs, it is a central factor in the signal transduction (Bronstein-Sitton et al., 2003; Jin et al., 2024). The downregulation or absence of CD247/CD3ζ is linked to reduced responsiveness in T cells and is commonly present in autoimmune diseases like rheumatoid arthritis and lupus (Dexiu et al., 2022). This mechanism also occurs in various chronic infectious diseases, including HIV and hepatitis C (Dexiu et al., 2022). However, it can also be a general regulatory process in T cells during infection, helping to maintain immune homeostasis and prevent excessive inflammation (Baniyash, 2004; van der Donk et al., 2021). Thus, the connection between CD247/CD3ζ downregulation during chronic inflammation and chronic infectious diseases has been well documented (Dexiu et al., 2022). Interestingly, we could show that expression of CD247 is entirely absent in infected Tercko/ko mice, while in the non-infected Tercko/ko mice expression of CD247 could be detected after 24 hr of infection. Hence, our data indicates that infection combined with deletion of Terc is associated with reduction of CD247 expression. Our study provides the first evidence of the total absence of CD247 expression during acute bacterial infection and inflammation (Figure 4). Previous work has already reported that constant stimulus with bacterial antigens reduces the expression of CD247/CD3ζ and impairs T cell function (Bronstein-Sitton et al., 2003). However, the complete absence of CD247/CD3ζ after a single antigenic stimulus, without chronic inflammation as well as the connection to knockout of Terc, are novel findings. These findings require further studies and investigations to gain a deeper understanding of the underlying mechanisms. Downregulation of CD247/CD3ζ is facilitated by myeloid suppressor cells (MSCs), which accumulate at the site of inflammation (Baniyash, 2004; Dexiu et al., 2022; Ezernitchi et al., 2006). MSCs are cells which exert an immunosuppressive function on T cells in response to inflammation or infection (Medina and Hartl, 2018). Thus MSCs contribute toward the regulation of the immune response to pathogens to prevent an overshooting reaction of the immune system (Medina and Hartl, 2018). However, their immunosuppressive function can also exacerbate infections. For instance, elevated levels of MSC induced T cell dysfunctionality and caused an exacerbated and sustained chronic infection in an S. aureus mouse model (Tebartz et al., 2015). Immunosuppression of T cells is conveyed by multiple mechanisms, one of which is the downregulation of CD247/CD3ζ (Ezernitchi et al., 2006). This process is facilitated among others by the ability of MSCs to metabolize the amino acid arginine, as arginine seems to be essential for expression of CD247 in T cells (Ezernitchi et al., 2006; Rodriguez et al., 2004). Interestingly, we could identify several MSC markers, such as lymphocyte antigen 6 family member G (LY6G), to be upregulated in the infected Tercko/ko mice. This suggests a potential role of MSCs in the downregulation of CD247/CD3ζ (Figure 5—figure supplement 1D). Notably, we could identify reduced expression of CD247 in infected old WT mice compared to young WT mice. Moreover, our sequencing data did not show an increase in CD247 expression in infected old WT mice compared to the non-infected control group, which further suggests that the T cells of old WT mice may also exhibit some level of dysfunction (Figure 4). One potential underlying mechanism is the reduced ability of aged macrophages to activate T cells due to diminished expression of the receptor required for presentation of the antigen (Herrero et al., 2001). Furthermore, T cells of aged individuals become increasingly deficient due to immunosenescence and exhaustion (Mittelbrunn and Kroemer, 2021). Supporting this, we could observe downregulation of CD27 compared to infected young WT mice, while CTLA4 was upregulated in infected old WT compared to uninfected mice (Figure 2—figure supplement 1E and F). Downregulation of CD28 and CD27 is part of T cell aging and an essential marker of T cell senescence, while upregulation of CTLA4 is part of a signature pointing to T cell exhaustion (Zhao et al., 2020). Interestingly, senescent T cells have shorter telomeres and exhibit reduced telomerase activity, which indicates a possible connection between Terc and T cell function (Mittelbrunn and Kroemer, 2021). Interestingly, CD28 expression was downregulated in infected Tercko/ko mice compared to old WT infected mice (Figure 4A and C). However, we did not observe any other relevant changes of T cell senescence or exhaustion markers in infected Tercko/ko mice (Figure 4A and C). Thus, T cell senescence could be a contributing factor to the T cell dysfunctionality, but likely does not explain the complete phenotype. The differences in the expression of T cell senescence and exhaustion markers, in addition to the lack of increased inflammation in old WT mice, indicate that mechanisms causing downregulation of parts of the TCR and T helper cell markers in old WT and Tercko/ko mice differ from each other. As T cell senescence is however a known consequence of Terc deletion, the lack of in depth investigation of this process in the present study is a limitation (Matthe et al., 2022). It is important to note that telomere shortening has a significant impact on the immune system (Chakravarti et al., 2021). Although young Tercko/ko mice were used in this study, telomere shortening is still likely to be a contributing factor. Therefore, further experiments investigating the role of T cell senescence in this model should be conducted. Nevertheless, old WT mice exhibit certain immune cell dysfunction similarities. However, given the intricate nature of aging, other mechanisms contribute to the distinct response observed in Tercko/ko and old WT mice following infection. This highlights the necessity of employing a knockout model to specifically examine the influence of Terc on infection, isolating it from the multifaceted processes involved in aging. We observed an increase in pro-inflammatory macrophages in the lungs of Tercko/ko mice during infection. To explore the role of macrophages in regulating T cell function during infection, we investigated whether AMs were sufficient to induce CD247/CD3ζ downregulation in T cells. While CD247/CD3ζ expression increased with bacterial stimulation in T cells from young WT mice, we failed to induce such an increase in CD247/CD3ζ expression in T cells from Tercko/ko mice (Figure 5). The expression pattern of CD247/CD3ζ was similar to that observed in the sequencing data, as initial levels of CD247/CD3ζ expression in non-infected Tercko/ko mice were higher than those of young WT mice. However, there was no significant reduction of CD247/CD3ζ after stimulation with bacteria in the T cells of Tercko/ko mice. One potential explanation for this finding is the absence of MSCs and other infiltrating cells, which can contribute to the inflammatory environment and lead to T cell dysfunction. Furthermore, after 24 but not 2 hr of infection, we observed a reduced release of the pro-inflammatory cytokine IL-1α from Tercko/ko T cells, suggesting a time-dependent reduction of T cell function. The results of the experiment conducted on T cells of Tercko/ko mice revealed an insufficient response to the bacterial stimulation, as there was no significant increase in CD247/CD3ζ expression or IL-1α release after 24 hpi. As total CD4+ T cells were analyzed in this study, it would be useful to investigate specific T cell populations such as memory and effector T cells to elucidate the potential mechanism leading to T cell dysfunctionality in further detail. Additionally, analysis of differences in immune cell recruitment to the lungs between young WT and Tercko/ko mice would be relevant. Thus, additional experiments are needed to validate and further investigate the underlying mechanisms leading to T cell dysfunctionality in Tercko/ko mice. Our data points toward the pivotal role of Terc in the regulation of inflammation as well as maintaining immune homeostasis during infection. We could demonstrate that S. aureus pneumonia in Tercko/ko mice resulted in an overshooting inflammation and activation of the NLRP3 inflammasome. The elevated inflammation eventually leads to T cell dysfunction, which impairs the host’s ability to mount an effective immune response against the pathogen, resulting in increased bacterial load and mortality. As T cell dysfunctionality is caused by the excessive inflammation, other pathogens inducing high inflammatory responses in the host could also lead to a similar phenotype in Tercko/ko mice (Figure 6). Graphical summary. Loss of Terc leads to an exaggerated inflammatory response and inflammasome activation upon S. aureus infection. This overactive inflammation disrupts T cell function, thereby impairing the immune response. Consequently, Tercko/ko mice show a significantly higher bacterial load and increased mortality following infection. Created with BioRender.com. Figure 6—figure supplement 1.Overview of the methods used in this publication.Created with BioRender.com. Overview of the methods used in this publication. Created with BioRender.com. This study linked T cell dysfunction to Terc deletion, which is supported by previous studies reporting a connection between reduced expression of Terc and apoptosis in human CD4+ T cells (Gazzaniga and Blackburn, 2014). These findings provide insights into possible mechanisms contributing to a more severe S. aureus pneumonia in the aging population. Materials and methods Bacteria All in vivo and in vitro experiments were carried out with the S. aureus strain USA300. S. aureus was cultivated in brain heart infusion medium (Thermo Fisher Scientific, Waltham, MA, USA) at 37°C while shaking at 150 rpm. The bacteria were harvested during the mid-logarithmic phase and adjusted to the appropriate optical density at 600 nm for the respective experiments in phosphate-buffered saline (PBS). The bacteria were then either used freshly for in vivo infection of mice or stored at –80°C until further usage in in vitro experiments. For heat-killing, the adjusted bacteria stock was incubated at 95°C for 5 min while shaking at 500 rpm. A fraction of the HK bacteria was plated on Müller-Hinton (MH) plates. Plates were incubated for 5 days at 37°C to confirm heat-killing of the bacteria. Determination of bacterial load Organs were homogenized in the appropriate amount of PBS (adjusted to their weight in mg) using a SpeedMill Plus (Analytik Jena, Jena, Germany). Homogenized organs and BAL fluid were diluted in a decadic dilution series and plated onto MH plates. Plates were incubated overnight at 37°C. Colonies were counted, and CFU per ml was calculated. Mouse models and infection Mouse in vivo experiments were approved by the Office for Consumer Protection of Thuringia (TV-Number: UKJ-19-028 and UKJ-22-023). G3 female Tercko/ko mice with a C57Bl/6 background were bred from homozygous parents in the animal facility of the Jena University Hospital. To confirm knockout of Terc, DNA was extracted from the tail of newborn mice using the DNeasy Blood & Tissue Kit (QIAGEN, Venlo, Netherlands) according to the manufacturer’s protocol. The DNA was then used for genotyping via PCR using the following primer sequences: mTR-R: 5′-TTC TGA CCA CCA CCA ACT TCA AT-3′; mTR-WT-F: 5′-CTA AGC CGG CAC TCC TTA CAA G-3′; 5PPgK(-F): 5′-GGG GCT GCT AAA GCG CAT-3′. The results were analyzed with an Agilent 2200 TapeStation system using a Agilent D1000 ScreenTape (both Agilent Technologies, Santa Clara, CA, USA). The WT Terc product had a size of 200 bp while the knockout product had a size of 180 bp. Only mice that showed a single band at 180 bp were used for the further breeding process. Tercko/ko mice aged 8 weeks were used for infection studies (n=8; non-infected=3; infected = 5). Female young WT (age 8 weeks) and old WT (age 24 months) C57Bl/6 mice (both n=10; non-infected=5; infected = 5) were purchased from Janvier Labs (Le Genest-Saint-Isle, France). All infected mouse cohorts were compared to their respective non-infected controls, as well as to the infected groups from other cohorts. Additionally, comparisons were made between the non-infected cohorts across all groups. All mice were anesthetized with 2% isoflurane before intranasal infection with S. aureus USA300 (1×108 CFU/20 µl) per mouse. After 24 hr, the mice were weighed and scored as previously described (Hornung et al., 2023). Infected Tercko/ko mice were grouped into different degrees of severity based on their clinical score, fatal outcome of the disease (fatal), and the presence of bacteria in organs other than the lung (systemic infection) for the indicated analysis. Mice with fatal infections were excluded from subsequent analyses, with only their final scores being reported. The mice were sacrificed via injection of an overdose of xylazine/ketamine and bleeding of axillary artery after 24 hpi. BAL was collected by instillation and subsequent retrieval of PBS into the lungs. Serum and organs were collected. Bacterial load in the BAL, kidney, and liver was determined by plating of serially diluted sample as described above. For this organs were previously homogenized in the appropriate volume of PBS. Gene expression was analyzed in the right superior lung lobe. Lobes were therefore homogenized in the appropriate amount of TRIzol LS reagent (Thermo Fisher Scientific, Waltham, MA, USA) prior to RNA extraction. The left lung lobe was embedded into Tissue Tek O.C.T. (Science Services, Munich, Germany) and stored at –80°C until further processing for histological analysis. Cytokine measurements were performed using the right inferior lung lobe. Lobes were previously homogenized in the appropriate volume of PBS. Remaining organs were stored at –80°C until further usage. Mouse studies were conducted without the use of randomization or blinding. Telomere length measurement The length of telomeres in the lung of young WT, old WT, and Tercko/ko mice was measured using the Absolute Mouse Telomere Length Quantification qPCR Assay Kit (ScienCell Research Laboratories, Carlsbad, CA, USA) according to the manufacturer’s protocol. Genomic DNA from the lungs was extracted by DNeasy Blood & Tissue Kit (QIAGEN, Venlo, Netherlands) according to the manufacturer’s protocol. For the PCR 2 ng of each sample was used. Average telomere length per chromosome end was calculated as described by the manufacturer. Histology and immunofluorescence Preparation and staining of tissue cryosections was performed as described previously (Hornung et al., 2023). For staining of S. aureus, rabbit anti- S. aureus polyclonal antibody (Cat. #PA1-7246, Thermo Fisher Scientific, Waltham, MA, USA) was diluted 1:400 in antibody diluent with background reducing components (Agilent, Santa Clara, CA, USA). Alexa Fluor 488 AffiniPure Donkey Anti-Rabbit IgG (Cat. #711-545-152, Jackson ImmunoResearch, West Grove, PA, USA) and BODIPY 558/568 phalloidin, which stains actin fibers (Cat. #B3475, Thermo Fisher Scientific, Waltham, MA, USA) were diluted in antibody diluent 1:500 and 1:400 respectively and applied to the slides as secondary antibodies. Immunocytochemistry Murine primary macrophages were fixed with 4% paraformaldehyde (PFA) for 15 min at 37°C, subsequently permeabilized with 0.1% Triton X-100, and blocked with 3% bovine serum albumin (BSA) in PBS for each 30 min at room temperature (RT). Cells were incubated overnight with either rabbit anti- S. aureus polyclonal antibody or rabbit anti-CD68 polyclonal antibody (Cat. # BOSSBS-0649R, VWR, Radnor, PA, USA) diluted 1:400 or 1:200 in 3% BSA in PBS, respectively. The following day, the slides were washed three times with PBS. Cy3-conjugated AffiniPure Donkey Anti-Rabbit IgG (Cat. #711-165-152, Jackson ImmunoResearch, West Grove, PA, USA) and Alexa Fluor Plus 647 Phalloidin (Cat. # A30107, Thermo Fisher Scientific, Waltham, MA, USA) were applied to the cells diluted 1:500 and 1:400 in 3% BSA in PBS respectively and incubated for 1 hr at RT. The cells were then mounted with DAPI Fluoromount-G. The immunofluorescence pictures were taken with an AxioObserver Z.1 microscope (Carl Zeiss AG, Oberkochen, Germany) and analyzed with the Zen software (Zen Pro v3.3). RNA extraction and mRNA sequencing RNA was extracted from murine lung tissue using the TRIzol/chloroform method. First, about 15 mg of lung tissue was homogenized in TRIzol LS reagent (Thermo Fisher Scientific, Waltham, MA, USA) using the SpeedMill Plus. The tissue-free supernatant of the homogenate was transferred into a new tube after centrifugation. 50 µl of chloroform was added to 250 µl TRIzol Reagent, incubated for 3 min at RT, and centrifuged at 12,000×g for 15 min at 4°C. The aqueous phase was mixed with isopropanol in a 1:2 ratio and incubated at RT for 10 min before centrifugation at 12,000×g for 10 min at 4°C. Afterward, the RNA pellet was washed twice with 75% ethanol. Finally, ethanol was removed, and the pellet was air-dried for 5–10 min. The dry pellet was then dissolved in sterile distilled water, and RNA concentration was determined by an ND-1000 NanoDrop spectrophotometer (PEQLAB Biotechnologie GmbH, Erlangen, Germany). Before sequencing, RNA integrity was measured using a 5400 Fragment Analyzer (Agilent Technologies, Santa Clara, CA, USA). RNA concentration and RNA integrity of the samples can be found in Supplementary file 1. Library construction and mRNA sequencing were performed by Novogene Co., LTD. (Beijing, China) using the Illumina platform NovaSeq 6000 S4 flowcell v1.0, based on the sequencing by synthesis mechanism and PE150 strategy. For bioinformatics analysis, raw reads in FASTQ format were first processed using fastp. Reads containing adapters and poly N sequences were removed as well as low quality reads to generate clean data. Clean reads were then mapped to the reference genome (Mus musculus [GRCm39/mm39]) with the HISAT2 software. Gene expression levels were quantified using the fpkm (fragments per kilobase of transcript per million fragments mapped) method. DESeq2 software as well as negative binomial distribution was used for analysis of differential gene expression. For FDR (false discovery rate) calculation the Benjamini-Hochberg procedure was used. A summary of the quality of the sequencing data of each sample can be found in Supplementary file 2. Heatmaps of the differentially expressed genes (DEGs) were constructed using R (v4.2.2; R Foundation for Statistical Computing, https://www.r-project.org/). Only significant DEGs (p-value<0.05) were displayed in the heatmaps. Non-significant genes were set to zero and are shown in white. All DEGs used for construction of the respective heatmaps are summarized in Supplementary file 3a-i . Immunophenotyping of the spleen Mice were sacrificed as described above, and spleens were freshly stored in cold 2% fetal calf serum (FCS) in PBS. For isolation of immune cells, spleens were mashed through a 70 µm cell strainer (Miltenyi Biotec, Bergisch Gladbach, Germany), and red blood cell lysis was performed by adding 5 ml of ammonium-chloride-potassium lysis buffer (Thermo Fisher Scientific, Waltham, MA, USA) for 5 min at 4°C to the pelleted cells. Cells were then counted, adjusted to 2×106 per ml PBS, and stained with BD Fixable Viability Stain 780 (BD Biosciences, Heidelberg, Germany) diluted 1:1000 in PBS for 15 min at RT. Non-specific binding of antibodies was blocked by incubating the samples with 3% rat serum in BD staining buffer (BD Biosciences, Heidelberg, Germany) for 5 min at RT. Anti-CD11c (Cat. #557401), anti-CD19 (Cat. #566412), anti-CD335 (Cat. #564069), anti-CD34 (Cat. #742971), anti-CD3ε (Cat. #553066), anti-Ly6G (Cat. #560601), and anti-F4/80 (Cat. #565411) were added to the samples in a dilution of 1:100 and incubated for 20 min at 4°C. All antibodies were purchased from BD Biosciences. Stained samples were measured with a BD Symphony A1 (BD Biosciences, Heidelberg, Germany), and analysis was performed with FlowJo v10.8.1. Detailed information on the gating strategy is presented in Figure 4—figure supplement 1A. Isolation and infection of murine T cells and AMs Tercko/ko and young WT mice were sacrificed. Killing for scientific purposes was conducted in accordance with the German animal welfare regulations. AMs were isolated as published elsewhere (Rios et al., 2017). In short, the murine lungs were washed out several times with PBS containing 0.5 mM ethylenediaminetetraacetic acid. The lavage was centrifuged at 350×g for 10 min at 4°C. The cell pellet was dissolved in Roswell Park Memorial Institute (RPMI) medium containing 20 mM HEPES and 5% FCS and counted. Subsequently, cells were seeded and incubated at 37°C for 2 hr. Lymphocytes were isolated from the spleen as described above. To subsequently isolate CD4+ T cells, cells were separated via magnetic cell separation. These cells were mixed with CD4+ beads and separated via MACS LS Columns (both Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s protocol. The purity of the resulting CD4+ T cell population was measured via flow cytometry using a BD Symphony A1 (BD Biosciences, Heidelberg, Germany). T cells were added to AMs for co-culture in a 1:1 ratio or cultured alone. For infection with HK S. aureus, an MOI of 5 was calculated, and the appropriate bacterial volume was added to each well. Cells were then incubated for 24 hr and harvested for downstream analysis. Cytokine measurement For cytokine measurements, the right inferior lung lobe was homogenized using a SpeedMill Plus in the appropriate volume of PBS to adjust the organs to their weight in mg. Then, the cytokines were measured with the LEGENDPlex mouse inflammation panel (BioLegend, San Diego, CA, USA) according to the manufacturer’s instructions. Samples were run in duplicates on the same plate. For the young WT and Tercko/ko cohort three biological replicates and for old WT cohorts five biological replicates were measured. Supernatants of co-cultured and single-cultured T cells were measured with the LEGENDPlex mouse T helper cytokine panel (BioLegend, San Diego, CA, USA). For each condition three biological replicates were measured. All samples were run on the same plate. Flow cytometry analysis was performed with a BD Symphony A1, and data analysis was carried out with the Qognit software v2023-02-15 (BD Biosciences, Heidelberg, Germany). Flow cytometry Co-cultured and single-cultured T cells were transferred to FACS tubes and centrifuged at 500×g for 5 min at 4°C. The supernatant was frozen for cytokine measurements, and the cell pellet was stained with PBS containing 1:1000 diluted BD Fixable Viability Stain 780 (Cat. #565388, BD Biosciences, Heidelberg, Germany) for 15 min at RT. Staining of surface markers was performed as described above. Samples were stained with anti-CD3ε (1:100, Cat. #553066), anti-CD25 (1:800, Cat. #553866), anti-CD69 (1:400, Cat. #551113), and anti-CD44 (1:100, Cat. #560569) for 30 min at 4°C. All antibodies were purchased from BD Pharmingen. Subsequently, samples were permeabilized and fixed. For this, the samples were centrifuged for 5 min at 500×g and 4°C, resuspended in BD Cytofix/Cytoperm buffer (BD Biosciences, Heidelberg, Germany), and incubated for 20 min at 4°C. Samples were washed once with BD Perm/Wash Buffer (BD Biosciences, Heidelberg, Germany). For intracellular staining, samples were stained with anti-CD247 (1:100, Cat. #ab91493, Abcam, Cambridge, UK) antibody in BD Perm/Wash Buffer for 30 min at 4°C. Lastly, the samples were washed and resuspended in BD Perm/Wash Buffer. Stained samples were measured with a BD Symphony A1 and analyzed with FlowJo v10.8.1. Detailed information on the gating strategy is presented in Figure 5—figure supplement 1B. Scanning electron microscopy T cells and AMs were isolated as described above. Cells were grown on poly-L-lysine (Merck Millipore, Burlington, MA, USA) coated glass coverslips in a 1:1 ratio. T cells were allowed to attach to the coverslips for 30 min before adding S. aureus. After adhesion of T cells, S. aureus USA300 was added at an MOI1 and incubated at 37°C. After 3.5 hr, the samples were fixed with freshly prepared modified Karnovsky fixative (4% wt/vol PFA, 2.5% vol/vol glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4) for 1 hr at RT. After washing each three times for 15 min with 0.1 M sodium cacodylate buffer (pH 7.4), the cells were post-fixed with 2% (wt/vol) osmium tetroxide for 1 hr at RT. Subsequently, the samples were dehydrated in ascending ethanol concentrations (30%, 50%, 70%, 90%, and 100%) for 15 min each. Next, the samples were critical-point dried using liquid CO2 and sputter coated with gold (thickness approx. 2 nm) using a CCU-010 sputter coater (safematic GmbH, Zizers, Switzerland). Finally, the specimens were investigated with a field emission SEM LEO-1530 Gemini (Carl Zeiss NTS GmbH, Oberkochen, Germany). Statistical analysis and scheme design Data are presented as mean ± SD, or as median with interquartile range for violin and box plots, with up to four levels of statistical significance indicated. p-Values were calculated using Kruskal-Wallis test. Individual replicates are represented as single data points. Statistical analysis was carried out using GraphPad Prism v9.0. In this manuscript, the authors sought to elucidate mechanistic intricacies of inflammatory responses, with emphasis on T cell dysfunction, to S. aureus-induced pneumonia in the context of aging process using Terc deficient mice. Conceptually, the study is very interesting with a set of useful findings. Although some experimental approaches are appropriate, the work as shown in the revised manuscript remains significantly underpowered and the absence of rigorous controls make this study incomplete in support of its claims. Summary: This work sets out to elucidate mechanistic intricacies in inflammatory responses in pneumonia in the context of aging process (Terc deficiency - telomerase functionality). Strengths: Very interesting, conceptually speaking, approach that is by all means worth pursuing. An overall proper approach to the posited aim. Weaknesses: The work is heavily underpowered and may have statistical deficits. This precludes at its current state drawing unequivocal conclusions. I remain at my initial position regarding the weaknesses. Summary The authors demonstrate heightened susceptibility of Terc-KO mice to S. aureus-induced pneumonia, perform gene expression analysis from the infected lungs, find an elevated inflammatory (NLRP3) signature in some Terc-KO but not control mice, and some reduction in T cell signatures. Based on that, they conclude that dysregulated inflammation and T cell dysfunction play a major role in these phenomena. The strengths of the work did not change, and include a problem not previously addressed (the role of Terc component of the telomerase complex) in certain aspects of resistance to bacterial infection and innate (and maybe adaptive) immune function. The weaknesses of this revised version still outweigh the strengths, because the authors did not substantially or experimentally answer the main criticism points, and have rather tried to argue away that which cannot be argued away. In summary, the most germane conclusions of this study remain plagued by flaws in experimental design, by lack of rigorous controls and by incomplete and inadequate approaches to testing of immune function. I will devote the rest of the comments to the revised manuscript and its success or lack thereof in responding to prior criticisms. Prior criticisms are again listed below in italics, to provide context for the attempts of the investigators to respond. (1) Reviewer 1 has justifiably criticized the exceptionally low power of the study, with 5 control and 3 experimental animals. The responding author has replied that the animal welfare laws preclude them from doing more experiments. That is unfortunate, and I sympathize with the authors. Nonetheless, in the absence of robust corroboration the rigor of the study remains severely compromised and the work is reduced to what I have pointed above - a preliminary and inconclusive study that is in need of deeper and more serious mechanistic investigation. (2) Terc-KO mice are a genomic knockout model, and therefore the authors need to carefully consider the impact of this KO on a wide range of tissues. This, however, is not the case. There are no attempts to perform cell transfers, use irradiation chimera or crosses that would be informative. In response to this criticism, the authors have quoted a whole bunch of papers characterizing different aspects of biology of these same mice. The most important paper in that regard would be the one by Matthe et al. on CD4 cells from these same mice. That study was limited and simply diagnosed in situ the changes in T cell pool, but did not decipher whether and to what extent such defects are cell-intrinsic or a byproduct of similarly altered microenvironments. Most importantly, none of that answers the original critique question of which cell types are truly the culprits in the Terc deletion phenotype presented here. As I indicated, one has to perform cell transfers, bone marrow irradiation chimera, additional genetic crosses and combinations thereof to substantiate whether the defects are ascribable to the lung tissue itself, the infiltrating myeloid cells, including macrophages, the T cells or a combination thereof. The authors provided none of this. (3) Throughout the manuscript the authors invoke the role of telomere shortening in aging, and according to them their Terc-KO mice should be one potential model for aging. Yet the authors consistently describe major differences between young Terc-KO and naturally aging old mice, with no discussion of the implications. This further confuses the biological significance of this work as presented. (4) Related to #2, group design for comparisons lacks a clear rationale. The authors stipulate that Terc-KO will mimic natural aging, but in fact, the only significant differences seen between groups in susceptibility to S. aureus are, contrary to the authors' expectation, between young Terc-KO and naturally old mice (Fig. 1A and B, no difference between young Terc-KO and young wt); or there are no significant differences at all between groups (Fig. 1, C, D,). I have also raised the issue of non-physiological nature of a germline Terc-KO, that does not mimic any known physiological or pathological state. The authors provided a non-response to this criticism. They argue in their response under (2) of their rebuttal that they included old mice as controls not for aging, because their experimental Terc-deletion mice were G3 and do not exhibit as much of a progeroid phenotype as G5 or G6 mice. But they still say in the revised formulation that these mice were infected "to explore the potential link to a fully developed aging phenotype". They just never conclude that no such link is substantiated by the vast majority of their data. Moreover, they come back to state in their response (4) that because the literature reported ".... reduction of Terc and Tert in tissues of old mice and rats. Therefore, as a potential immunomodulatory factor reduced Terc expression could be connected to age-related pathologies." So either they have used old mice here to compare aging phenotypes, and found that Terc-KO mice diverge massively from aging phenotypes, in which case they have to state so, or they are not using them as age comparators (in which case I am not sure what their purpose is). (5) (originally part of criticism #4) I have criticized inadequate group design is when the authors begin dividing their Terc-KO groups by clinical score into animals with or without "systemic infection" (the condition where a bacterium spreads uncontrollably across the many organs and via blood, which should be properly called sepsis), and then compare this sepsis group to other groups (Suppl Fig. 1G; Fig. 2; lines 374-376 and 389-391). .... Most importantly, methodologically it is highly inappropriate to compare one mouse with sepsis to another one without. If Terc-KO mice with sepsis are a comparator group, then their controls have to be wild type mice with sepsis, who are dealing with the same high bacterial load across the body and are presumably forced to deploy the same set of immune defenses. The authors responded by making me aware of the 2016 JAMA definition of sepsis that invokes "a life-threatening organ dysfunction caused by a dysregulated host response to infection". I appreciate the correction, and note that in a human setting and globally, such a definition may make sense. The authors stated that bacteremia and not sepsis should be used as a criterion. I agree, and per my original criticism, believe it will be appropriate to compare bacteremic wt and KO mice. (6) I am shortening my prior critique to make it more to the point that was not addressed: The authors conclude that disregulated inflammation and T cell dysfunction play a major role in S. aureus susceptibility. This may or may not be an important observation, because many KO mice are abnormal for a variety of reasons, and until such reasons are mechanistically dissected, the physiological importance of the observation will remain unclear. ....., the authors truly did not examine the key basic features of their model, including the features of basic and induced inflammatory and immune response. This analysis could be done either using model antigens in adjuvants, defined innate immune stimuli (e.g. TLR, RLR or NLR agonsists), or microbial challenge. The only data provided along these lines are the baseline frequencies of total T cells in the spleen of the three groups of mice examined (not statistically significant, Fig. 4B). We do not know if the composition of naïve to memory T cell subsets may have been different, and more importantly, we have no data to evaluate whether recruitment of the immune response (including T cells) to the lung upon microbial challenge is similar or different. So, what are the numbers and percentages of T cells and alveolar macrophages in the lung following S. aureus challenge and are they even comparable or are there issues in mobilizing the T cell response to the site of infection ? If, for example, Terc-KO mice do not mobilize enough T cells to the lung during infection, that would explain paucity in many T cell -associated genes in their transcriptomic set that they authors report. That in turn may not mean dysfunction of T cells but potentially a whole different set of defects in coordinating the response in Terc-KO mice. The authors did not respond to this criticism other than to provide more frequencies of different subsets. The key here are the NUMBERS of cells present at the peak of challenge, or better yet the kinetics of cell accumulation (again numbers), as well as transfer experiments to establish where the defect actually lies (mobilization, activation, proliferation, etc.). (7) Related to that, immunological analysis is also inadequate. First, the authors pull signatures from the total lung tissue, which is both imprecise and potentially skewed by differences not in gene expression but in types of cells present and/or their abundance, a feature known to be affected by aging and perhaps by Terc deficiency during infection. Second, to draw any conclusions about immune responses, the authors would have to track antigen-specific T cells, which is possible for a wide range of microbial pathogens using peptide-MHC multimers. This would allow highly precise analysis of phenomena the authors are trying to conclude about. Moreover, it would allow them to confirm their gene expression data in populations of physiological interest. The authors agreed that this would be of interest but did nothing to provide it. They provided a sentence in the discussion stating that this (as well as many other experiments needed to interpret the results) would be of interest. (8) Overall, the authors begun to address the role of Terc in bacterial susceptibility, but to what extent that specifically involves inflammation and macrophages, T cell immunity or aging remains unclear at the present. My conclusion from the prior review remains unchanged in the face of the revision that did not answer most of the previous criticism. The study as it stands is inconclusive and highly preliminary, with lack of clearly defined mechanistic underpinnings. The following is the authors’ response to the original reviews. Public Reviews: Reviewer #1 (Public Review): Summary: This work sets out to elucidate mechanistic intricacies in inflammatory responses in pneumonia in the context of the aging process (Terc deficiency - telomerase functionality). Strengths: Very interesting, conceptually speaking, approach that is by all means worth pursuing. An overall proper approach to the posited aim. We want to thank the reviewer for taking the time to review our manuscript and for providing positive feedback regarding our research question. Weaknesses: The work is heavily underpowered and may have statistical deficits. This precludes it in its current state from drawing unequivocal conclusions. Thank you for this essential and valuable comment. We fully accept that the small sample size of the Tercko/ko mice is a major limitation of our study and transparently discuss this in our manuscript. However, due to Animal Welfare regulations, only a reduced number of mice were approved because of the strong burden of disease. Consequently, only three non-infected and five infected mice were available to us. This reduced number of mice presents a clear limitation to our study. However, due to ethical considerations related to animal welfare and sustainability, as well as compliance with German animal welfare regulations, it is not possible to obtain additional Tercko/ko mice to increase the dataset. The animal studies are an important aspect of our study; however, our hypothesis was also investigated at multiple levels, including in an in vitro co-culture model (Figure 5), to ensure comprehensive analysis. Thus, we clearly demonstrated that S. aureus pneumonia in Tercko/ko mice leads to a more severe phenotype, orchestrated by the dysregulation of both innate and adaptive immune response. Reviewer #2 (Public Review): Summary: The authors demonstrate heightened susceptibility of Terc-KO mice to S. aureus-induced pneumonia, perform gene expression analysis from the infected lungs, find an elevated inflammatory (NLRP3) signature in some Terc-KO but not control mice, and some reduction in T cell signatures. Based on that, They conclude that disregulated inflammation and T-cell dysfunction play a major role in these phenomena. Strengths: The strengths of the work include a problem not previously addressed (the role of the Terc component of the telomerase complex) in certain aspects of resistance to bacterial infection and innate (and maybe adaptive) immune function. We would like to thank the reviewer for the positive feedback regarding our aim to investigate the impact of Terc deletion on the pulmonary immune response to S. aureus. Weaknesses: The weaknesses outweigh the strengths, dominantly because conclusions are plagued by flaws in experimental design, by lack of rigorous controls, and by incomplete and inadequate approaches to testing immune function. These weaknesses are as follows (1) Terc-KO mice are a genomic knockout model, and therefore the authors need to carefully consider the impact of this KO on a wide range of tissues. This, however, is not the case. There are no attempts to perform cell transfers or use irradiation chimera or crosses that would be informative. We thank the reviewer for bringing up this important point. The aim of our study, however; was to investigate the impact of Terc deletion in the lung and on the response to bacterial pneumonia, rather than to provide a comprehensive characterization of the Tercko/ko model itself. This characterization of different tissues and cell types has already been conducted by previous studies. For instance, studies that characterize the general phenotype of the model (Herrera et al., 1999; Lee et al., 1998; Rudolph et al., 1999) but also investigations that shed light on the impact of Terc deletion on specific cell types such as microglia (Khan et al., 2015) or T cells (Matthe et al., 2022). The impact of Terc deletion on T cells is also discussed in our manuscript in lines 89 to 105. Furthermore, a section about the general phenotype of the Terc deletion model is included in the introduction in lines 126 to 138. Thus we discussed the relevant literature regarding Tercko/ko mice in our manuscript and attempted to provide a more in-depth characterization of the lung by investigating the inflammatory response to infection as well as changes in the gene expression (Figure 2-4). (2) Throughout the manuscript the authors invoke the role of telomere shortening in aging, and according to them, their Terc-KO mice should be one potential model for aging. Yet the authors consistently describe major differences between young Terc-KO and naturally aging old mice, with no discussion of the implications. This further confuses the biological significance of this work as presented. Thank you for mentioning this relevant point. We want to apologize for the confusion regarding this matter. While Tercko/ko mice are a well-established model for premature aging, these effects become more apparent with increasing generations (G) and thus, G5 and 6 mice are the most affected by Terc deletion (Lee et al., 1998; Wong et al., 2008). Thus, while Tercko/ko mice are a common model for premature aging, this accelerated aging phenotype is predominantly apparent in later-generation Tercko/ko (G5 and 6) or aged Tercko/ko mice (Lee et al., 1998; Wong et al., 2008). Since the aim of this study was to analyze the impact of Terc deletion on the lung and its immune response to bacterial infections instead of the impact of telomere shortening and telomerase dysfunction, young G3 Tercko/ko mice (8 weeks) were used in this study. This is also mentioned in the lines 131-134. In this study, Tercko/ko mice were used not as a model of aging, but rather as a model specifically for Terc deletion. The old WT mice function as a control cohort to observe possible common but also deviating effects between aging and Terc deletion. In our sequencing data, we observe that uninfected young WT mice are very similar to uninfected Tercko/ko mice. Other studies have also reported this lack of major differences between uninfected WT and Tercko/ko mice in the G3 knockout mice (Kang et al., 2018). Conversely, uninfected young WT and Tercko/ko mice exhibited great differences, for instance, regarding the numbers of differentially expressed genes (Supplemental Figure 1H). Thus, differences between naturally aged mice and young G3 Tercko/ko mice are not surprising. To clarify this aspect we reconstructed the paragraph discussing the Tercko/ko mice (lines 126-134). Additionally we added a paragraph explaining the purpose of the naturally aged mice to the lines 134 to 138: “As control cohort age-matched young WT mice were utilized. To investigate whether Terc deletion, beyond critical telomere shortening, impacts the pulmonary immune response, we used young Tercko/ko mice. Additionally, naturally aged mice (2 years old) were infected to explore the potential link to a fully developed aging phenotype.” (3) Related to #2, group design for comparisons lacks a clear rationale. The authors stipulate that TercKO will mimic natural aging, but in fact, the only significant differences seen between groups in susceptibility to S. aureus are, contrary to the authors' expectation, between young Terc-KO and naturally old mice (Figures 1A and B, no difference between young Terc-KO and young wt); or there are no significant differences at all between groups (Figures 1, C, D,). We thank the reviewer for this essential comment. As mentioned above the Tercko/ko mice in this study are not selected to model natural aging. To model telomerase dysfunction and accelerated aging selection of later generation or aged Tercko/ko mice would have been more suitable. The lack of statistical significance in some figures is likely due to the heterogeneity of disease phenotype of S. aureus infection in mice, which is a limitation of our study that we discuss in our discussion section in lines 576-582. The phenotype of S. aureus infection can vary greatly within a mouse population, highlighting the limitations of mice as a model for S. aureus infections. To account for this heterogeneity we divided the infected Tercko/ko mice cohort into different degrees of severity based on the clinical score and the presence of bacteria in organs other than the lung (mice with systemic infection). Despite the heterogeneity especially within the Tercko/ko mice cohort the differences between the knockout and young as well as old WT mice were striking. Including the fatal infections, 80% of the Tercko/ko mice had a severe course of disease, while none of the WT mice displayed a severe course (Figure 1A, B and Supplemental Figure 1A, B). This hints towards a clear role of Terc in the response to S. aureus infection in mice. Thus while in some figures the differences are not significant, strong trends towards a more severe phenotype of S. aureus infection in the Tercko/ko mice regarding bacterial load, score and inflammatory response could be observed in our study. Another example of inadequate group design is when the authors begin dividing their Terc-KO groups by clinical score into animals with or without "systemic infection" (the condition where a bacterium spreads uncontrollably across the many organs and via blood, which should be properly called sepsis), and then compare this sepsis group to other groups (Supplementary Figures 1G; Figure 2; lines 374-376 and 389391). This gives them significant differences in several figures, but because they did not clearly indicate where they applied this stratification in the figure legends, the data are somewhat confusing. Most importantly, methodologically it is highly inappropriate to compare one mouse with sepsis to another one without. If Terc-KO mice with sepsis are a comparator group, then their controls have to be wild-type mice with sepsis, who are dealing with the same high bacterial load across the body and are presumably forced to deploy the same set of immune defenses. We sincerely appreciate the significant time and effort you have invested in reviewing our manuscript. However, with all due respect, we must point out that the definition of sepsis you have referenced is considered outdated. According to the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), sepsis is defined as "a life-threatening organ dysfunction caused by a dysregulated host response to infection" (Marvin Singer, 2016, JAMA). Given this fundamental misunderstanding of our findings, we find the comment regarding the inadequacy of our groups to be both dismissive and lacking in scientific merit. We would like to emphasize that the group size used in our study is consistent with accepted standards in infection research. We strongly reject any insinuations of inadequacy that have been repeatedly mentioned throughout the review. In order to provide a nuanced investigation of disease severity in Tercko/ko mice, we added the term “systemic infection” to the figures whenever the mice were divided into groups of mice with and without systemic infection. This is the case for Figure 2A and Supplemental Figure 1C-E. The division into mice with and without systemic infection is also mentioned in the figure legend of Figure 2A in lines 932 to 935 and for Supplemental Figure 1 in lines 1052-1053. We agree that Supplemental Figure 1G is somewhat confusing as the mice with systemic infection are highlighted in this graph but not included as a separate group within our sequencing analysis. We added a sentence to the figure legend clarifying this (lines 1042-1044): “Nevertheless, the infected Tercko/ko mice were considered one group for the expression analysis and not split into separate groups for the subsequent analysis.” Additionally, we revised the section regarding this grouping in different degrees of severity in our Material and Methods section to clarify that this division was only performed for specific analysis (line 191): “…for the indicated analysis.” Furthermore, the mice which were classified as systemically infected mice were not septic mice, as mentioned above. Those mice were classified by us as systemically infected based on their clinical score and the presence of bacteria in other organs than the lung as stated in the lines 188-191 and 377-381. Bacteremia is a symptom of very severe cases of hospital-acquired pneumonia with a very high mortality (De la Calle et al., 2016). Therefore, the systemically infected mice or rather mice with bacteremia display an especially severe pneumonia phenotype, which is distinct from sepsis. The presence of this symptom in our Tercko/ko mice further highlights the clinical relevance of our study. This aspect was added to the manuscript in the lines 568-570. “The detection of bacteria in extra pulmonary organs is of particular interest, as bacteremia is a symptom of severe pneumonia and is associated with high mortality (De la Calle et al., 2016).” (4) The authors conclude that disregulated inflammation and T-cell dysfunction play a major role in S. aureus susceptibility. This may or may not be an important observation, because many KO mice are abnormal for a variety of reasons, and until such reasons are mechanistically dissected, the physiological importance of the observation will remain unclear. Two points are important here. First, there is no natural counterpart to a Terc-KO, which is a complete loss of a key non-enzymatic component of the telomerase complex starting in utero. Second, the authors truly did not examine the key basic features of their model, including the features of basic and induced inflammatory and immune responses. This analysis could be done either using model antigens in adjuvants, defined innate immune stimuli (e.g. TLR, RLR, or NLR agonists), or microbial challenge. The only data provided along these lines are the baseline frequencies of total T cells in the spleen of the three groups of mice examined (not statistically significant, Figure 4B). We do not know if the composition of naïve to memory T cell subsets may have been different, and more importantly, we have no data to evaluate whether recruitment of the immune response (including T cells) to the lung upon microbial challenge is similar or different. So, what are the numbers and percentages of T cells and alveolar macrophages in the lung following S. aureus challenge and are they even comparable or are there issues in mobilizing the T cell response to the site of infection? If, for example, Terc-KO mice do not mobilize enough T cells to the lung during infection, that would explain the paucity in many T-cellassociated genes in their transcriptomic set that the authors report. That in turn may not mean dysfunction of T cells but potentially a whole different set of defects in coordinating the response in Terc-KO mice. We thank the reviewer for highlighting these important aspects. Regarding the first point, indeed there is no naturally occurring deletion of Terc in humans. However, studies reported reduced expression of Terc and Tert in the tissues of aged mice and rats (Tarry-Adkins et al., 2021; Zhang et al., 2018). Terc itself has been found to have several important immunomodulatory functions such as the activation of the NFκB or PI3-kinase pathway (Liu et al., 2019; Wu et al., 2022). As those aforementioned pathways are relevant for the immune response to S. aureus infections, the authors were interested in exploring the impact of Terc deletion on the pulmonary immune response. The potential immunomodulatory functions of Terc are discussed in lines 106-121. To further clarify our rationale we added a sentence to the introduction in lines 121-125. “Interestingly, downregulation of Terc and Tert expression in tissues of aged mice and rats has been found (Tarry-Adkins, Aiken, Dearden, Fernandez-Twinn, & Ozanne, 2021; Zhang et al., 2018). Therefore, as a potential immunomodulatory factor reduced Terc expression could be connected to agerelated pathologies.” Regarding the second point, as we focused on the effect of Terc deletion in the lung and its role in S. aureus infection, we investigated inflammatory and immune response parameters relevant to this setting. For instance, inflammation parameters in the lungs of all three mice cohorts were measured to investigate differences in the inflammatory response in the non-infected and infected mice (Figure 2A). Those measurements showed no baseline difference in key inflammatory parameters between young WT and Tercko/ko mice, which is consistent with previous findings (Kang et al., 2018). The inflammatory response to infection with S. aureus in the Tercko/ko mice cohort differed significantly from the other cohorts (Figure 2A), hinting towards a dysregulated inflammatory response due to Terc deletion. Furthermore, we investigated general immune cell frequencies such as dendritic cells, macrophages, and B cells in the spleen of all three mice cohorts to gather a baseline understanding of the general immune cell populations. In our manuscript only total T cell frequencies were included due to its relevance for our data regarding T cells (Figure 4B). This data could show that there was no difference of total amount of T cells in the spleen of all three mice cohorts. For a more detailed insight into our analysis we added the frequencies of the other immune cell populations analyzed in the spleen as a Supplemental Figure 3B-F. Additionally, a figure legend for the graphs was added to lines 1075-1094. Therefore, while we did not analyze baseline frequencies of specific populations of T cells, we analyzed and characterized the inflammatory and immune response of our model in a way relevant to our research question. The differences observed in T cell marker and TCR gene expression was also partly present between the uninfected and infected Tercko/ko mice such as the complete absence of CD247 expression in infected Tercko/ko, which is however expressed in uninfected mice of this cohort (Figure 4A, C and D). Thus, this effect cannot be solely attributed to an inadequate mobilization of T cells to the lung after infectious challenge. However, we agree that a more detailed insight into recruited immune cells to the lung or frequencies of different T cell populations could contribute to a better understanding of the proposed mechanism and would be an interesting experiment to conduct in further studies. We accept this as a limitation of our study and included it in our discussion section in lines 719-723: “As total CD4+ T cells were analyzed in this study, it would be useful to investigate specific T cell populations such as memory and effector T cells to elucidate the potential mechanism leading to T cell dysfunctionality in further detail. Additionally, analysis of differences in immune cell recruitment to the lungs between young WT and Tercko/ko mice would be relevant.” (5) Related to that, immunological analysis is also inadequate. First, the authors pull signatures from the total lung tissue, which is both imprecise and potentially skewed by differences, not in gene expression but in types of cells present and/or their abundance, a feature known to be affected by aging and perhaps by Terc deficiency during infection. Second, to draw any conclusions about immune responses, the authors would have to track antigen-specific T cells, which is possible for a wide range of microbial pathogens using peptide-MHC multimers. This would allow highly precise analysis of phenomena the authors are trying to conclude about. Moreover, it would allow them to confirm their gene expression data in populations of physiological interest We thank the reviewer for highlighting this important and relevant point. In our study, we aimed to investigate the role of Terc expression in modulating inflammation and the immune response to S. aureus infection in the lung. To address this, we examined the overall impact of age, genotype, and infection on lung inflammation and gene expression. Therefore, sequencing of total lung tissue was essential for addressing the research question posed. Our findings demonstrate that Tercko/ko mice exhibit a more severe phenotype following S. aureus infection, characterized by an increased bacterial load and heightened lung inflammation (Figures 1 and 2). Furthermore, our data suggest that Terc plays a role in regulating inflammation through activation of the NLRP3 inflammasome, along with the dysregulation of several T cell marker genes (Figures 2, 4, and 5). However, this study lacks a detailed analysis of distinct T cell populations, including antigen-specific T cells, as noted earlier. Investigating these aspects in future studies would be valuable to validate and expand upon our findings. We have incorporated these suggestions into the discussion section (lines 719-723) “As total CD4+ T cells were analyzed in this study, it would be useful to investigate specific T cell populations such as memory and effector T cells to elucidate the potential mechanism leading to T cell dysfunctionality in further detail. Additionally, analysis of differences in immune cell recruitment to the lungs between young WT and Tercko/ko mice would be relevant.” Nevertheless, our study provides first evidence of a potential connection between T cell functionality and Terc expression. Third, the authors co-incubate AM and T cells with S. aureus. There is no information here about the phenotype of T cells used. Were they naïve, and how many S. aureus-specific T cells did they contain? Or were they a mix of different cell types, which we know will change with aging (fewer naïve and many more memory cells of different flavors), and maybe even with a Terc-KO? Naïve T cells do not interact with AM; only effector and memory cells would be able to do so, once they have been primed by contact with dendritic cells bringing antigen into the lymphoid tissues, so it is unclear what the authors are modeling here. Mature primed effector T cells would go to the lung and would interact with AM, but it is almost certain that the authors did not generate these cells for their experiment (or at least nothing like that was described in the methods or the text). Thank you for bringing up this important question. For the co-cultivation experiment of T cells and alveolar macrophages, total CD4+ T cells of both young WT and Tercko/ko were used. We did not select for a specific population of T cells. Our sequencing data indicated the complete downregulation of CD247 expression, which is an important part of the T cell receptor, in the lungs of infected Tercko/ko mice (Figure 4A, C and D). Given that this factor is downregulated under chronic inflammatory conditions, we investigated the impact of the inflammatory response in alveolar macrophages on the expression of various T cell-derived cytokines, as well as CD247 expression (Figure 5D, E) (Dexiu et al., 2022). This aspect is also highlighted in the discussion in lines 622-636. Therefore, a co-cultivation model of T cells and alveolar macrophages was established and confronted with heat-killed S. aureus to elicit an inflammatory response of the macrophages. To emphasize this purpose, we have revised our statement about the model setup in lines 516-518 of the manuscript: “An overactive inflammatory response could be a potential explanation for the dysregulated TCR signaling.” The authors hope this will clarify the intent behind the model setup. (6) Overall, the authors began to address the role of Terc in bacterial susceptibility, but to what extent that specifically involves inflammation and macrophages, T cell immunity, or aging remains unclear at present. We thank the reviewer for the helpful and relevant comments. The authors accept the limitations of the presented study such as the reduced number of Tercko/ko mice and the limitations of murine models for S. aureus infection itself and discuss those in the discussion section in the lines 558-560; 576-582; 688-690 and 719-725. However, we hope that our responses have provided sufficient evidence to convince the reviewer that our data supports a clear role for Terc expression in regulating the immune response to bacterial infections, particularly with respect to inflammation and its potential connection to T cell functionality. Recommendations for the authors: Reviewer #1 (Recommendations For The Authors): The good element first: I read this paper with genuine interest and applaud the authors for investigating the posited question. I consider it by all means scientifically relevant in the context of physiological/pathophysiological aging and reaction to a disease (here pneumonia). The Terc deletion model looks very appropriate for the question and the methodology is very advanced/in-depth. The data flow/selection of endpoints and assays is very logical to me. Moreover, I like the breakdown of pneumonia into varying levels of severity. We thank the reviewer for their time and effort taken to revise our manuscript. Additionally, we are grateful to receive your positive feedback regarding our study design and research question. The weaknesses: (1) I cannot help but notice that the study is heavily underpowered. As such, it is inadmissible. The key reason is that it is the first of its kind and seminal findings must be strongly propped by the evidence. It is apparent to me that the data scatter presented in the figures tends to be abnormally distributed (e.g. obvious bimodal distribution in some groups). Therefore, the presented comparisons (even if stat. sign) can be heavily misleading in terms of: (i) the true magnitude of the observed effects and (ii) possible type 2 error in some cases of p value >0.05. Solution: repeat the study to ensure reasonable power/reliability. This will also make it stronger as it will immediately demonstrate its reproducibility (or lack of it). Thank you for bringing up this extremely relevant point. We acknowledge the issue of the small sample size of Tercko/ko mice as a major limitation of our study. This limitation is also included in our discussion section in the lines 558-560. Thus we fully agree with this limitation and transparently discuss this in our manuscript. However, due to the strict German animal welfare regulations it is not possible to obtain more Tercko/ko mice, as mentioned above. Furthermore, since fatal infections occurred in the Tercko/ko mice cohort we had a reduced number of mice available. However, the differences between the Tercko/ko and WT mice were striking. Including the fatal infections 80% of the Tercko/ko mice had a severe course of disease, while none of the WT mice displayed a severe course. This hints towards a clear role of Terc in the response to S. aureus infection in mice. (2) In the stat analysis section of M&Ms, the authors feature only 1 sentence. This cannot be. A detailed stats workup needs to be included there. This is very much related to the above weakness; e.g. it is impossible to test for normality (to choose an appropriate post-hoc test) with n=3. Back to square one: study underpowered. We thank the reviewer for highlighting this important aspect. We carefully revised the method section in lines 357-360 to include all relevant information: “Data are presented as mean ± SD, or as median with interquartile range for violin and box plots, with up to four levels of statistical significance indicated. P-values were calculated using Kruskal-Wallis test. Individual replicates are represented as single data points.” (3) Pneumonia severity. While I noted that as a strength, I also note it as weakness here. It looks to me like the authors stopped halfway with this. I totally support testing a biological effect(s) such as the one investigated here across a spectrum of a given disease severity. The authors mention that they had various severity phenotypes produced in their model but this is not visible in the data figs. I strongly suggest including that as well; i.e., to study the posited question in the severe and mild pneumonia phenotype. This is a very smart path and previous preclinical research clearly demonstrated that this severe/mild distinction is very relevant in the context of the observed responses (their presence/absence, longevity, dynamics, etc). I realize this is challenging, thus, I would probably use this approach in the Terc k/o model as sort of a calibrator to see whether the exacerbation observed in the current setup (severe?) will be also present in a mild pneumonia phenotype. S. aureus can be effectively titrated to produce pneumonia of varying severity. We thank the reviewer for bringing up this relevant point. In our study, we could observe heterogeneity within the infected Tercko/ko cohort. Therefore as pointed out by the reviewer we assigned different degrees of severity to those groups based on clinical scores, the fatal outcome of the disease (fatal subgroup), and the presence of bacteria in organs other than the lungs (systemic infection subgroup) as stated in our materials and methods part in the lines 188-191 (Supplemental Figure 1A and B). Moreover, we highlighted this difference in a number of our figures. For example, when categorizing the mice into groups with and without systemic infection, we noticed that the mice with systemic infection demonstrated a higher bacterial load, significant body weight loss, and increased lung weight (see Supplemental Figure 1C-E). Interestingly, the two mice with systemic infection clustered separately from the other mice, indicating that the mice with systemic infection are transcriptomically distinct from the other mice cohorts (Supplemental Figure 1G). Additionally, the inflammatory response was exclusively elevated in the lungs of mice with systemic infection (Figure 2C). Thus, we included this distinction in several figures and attempted to study the differences between those subgroups but also their similarities. For instance, we could observe that some changes in the transcriptome were present in all three infected Tercko/ko mice such as the complete absence of CD247 expression at 24 hpi (Figure 4D). This distinction therefore provided a more detailed insight into the underlying mechanisms of disease severity in Tercko/ko mice and is lacking in other studies. We agree with the reviewer, that a study investigating mild and severe pneumonia phenotypes would be clinically relevant. However, as noted above, due to ethical considerations related to animal welfare and sustainability, as well as compliance with German animal welfare regulations, it is not possible to obtain additional Tercko/ko mice to carry out the proposed experiment. (4) Please read ARRIVE guidelines and note the relevant info in M&Ms as ARRIVE guidelines point out. Thank you for emphasizing this crucial aspect. We revised our materials and methods section according to the ARRIVE guidelines (lines 179-206). “Tercko/ko mice aged 8 weeks, were used for infection studies (n = 8; non-infected = 3; infected = 5). Female young WT (age 8 weeks) and old WT (age 24 months) C57Bl/6 mice (both n = 10; non-infected = 5; infected = 5) were purchased from Janvier Labs (Le Genest-Saint-Isle, France). All infected mouse cohorts were compared to their respective non-infected controls, as well as to the infected groups from other cohorts. Additionally, comparisons were made between the non-infected cohorts across all groups. All mice were anesthetized with 2% isoflurane before intranasal infection with S. aureus USA300 (1x108 CFU/20µl) per mouse. After 24 hours, the mice were weighed and scored as previously described (Hornung et al., 2023). Infected Tercko/ko mice were grouped into different degrees of severity based on their clinical score, fatal outcome of the disease (fatal) and the presence of bacteria in organs other than the lung (systemic infection) for the indicated analysis. Mice with fatal infections were excluded from subsequent analyses, with only their final scores being reported. The mice were sacrificed via injection of an overdose of xylazine/ketamine and bleeding of axillary artery after 24 hpi. BAL was collected by instillation and subsequent retrieval of PBS into the lungs. Serum and organs were collected. Bacterial load in the BAL, kidney and liver was determined by plating of serially diluted sample as described above. For this organs were previously homogenized in the appropriate volume of PBS. Gene expression was analyzed in the right superior lung lobe. Lobes were therefore homogenized in the appropriate amount of TriZol LS reagent (Thermo Fisher Scientific, Waltham, MA, US) prior to RNA extraction. The left lung lobe was embedded into Tissue Tek O.C.T. (science services, Munich, Germany) and stored at 80°C until further processing for histological analysis. Cytokine measurements were performed using the right inferior lung lobe. Lobes were previously homogenized in the appropriate volume of PBS. Remaining organs were stored at -80°C until further usage. Mouse studies were conducted without the use of randomization or blinding.“ (5) There are also some other descriptive deficits but they are of a much smaller caliber so I do not list them. We thank the reviewer for their valuable and insightful suggestions for improving our manuscript. We hope that our responses and the corresponding revisions address these suggestions satisfactorily. Concluding: the investigative idea is great/interesting and the methodological flow is adequate but the low power makes this study of low reliability in its current form. I strongly urge the authors to walk the extra mile with this work to make it comprehensive and reliable. Best of luck! Reviewer #2 (Recommendations For The Authors): (1) Many legends are uninformative and do not contain critical information about the experiments. For example, Figure 2A with cytokine measurements (in lung homogenates?) is likely showing data from an ELISA or Luminex test, but there is no mention of that in the legend. It stands next to Figure 2B, which is a gene expression map, again, likely from the lung (prepared how, normalized how, etc?) lacking even the most basic information. Further, Figure 2D has no information on the meaning/effect size of gene ratios on the x-axis. Figures 3 and 4 are presumably the subsets of their transcriptome data set (whole lung, harvested on d ?? post-infection), but that is just a guess on my part. Even in the main text, the timing and the controls for the transcriptomic study are not stated (ln. 398 and onwards). The authors really need to revise the figure legends and provide all the details that an average reader would need to be able to interpret the data. We thank the reviewer for bringing up this important point. The figure legends of all figures including supplemental figures were revised to ensure they include all relevant data necessary for accurate interpretation of the graphs. Additionally, we clarified the sequenced samples in lines 427-429: “We performed mRNA sequencing of the murine lung tissue of infected and non-infected mice at 24 hpi to elucidate potential differentially expressed genes that contribute to the more severe illness of Tercko/ko mice.” (2) Telomere shortening affects differentially different cells and its role in aging is nuanced - different in mesenchymal cells with no telomerase induction, in non-replicating cells, and in hematopoietic cells that can readily induce telomerase. The authors should be mindful of that in setting up their introduction and discussion. Thank you for mentioning this essential aspect. We revised our introduction and discussion to reflect the nuanced role of telomerase shortening in different tissues (lines 83-92 and 690-695): “Telomerase activity is restricted to specific tissues and cell types, largely dependent on the expression of Tert. While Tert is highly expressed in stem cells, progenitor cells, and germline cells, its expression is minimal in most differentiated cells (Chakravarti, LaBella, & DePinho, 2021). Consequently, the impact of telomerase dysfunction on tissues varies according to their self-renewal rate. (Chakravarti et al., 2021). One important aspect of telomere dysfunction is the impact of telomere shortening on the immune system as well as the hematopoietic system. Tissues or organ systems that are highly replicative, such as the skin or the hematopoietic system, are affected first by telomere shortening (Chakravarti et al., 2021).” “It is important to note that telomere shortening has a significant impact on the immune system. Although young Tercko/ko mice were used in this study, telomere shortening is still likely to be a contributing factor. Therefore, further experiments investigating the role of T cell senescence in this model should therefore be conducted.” (3) Syntax and formulations need to be improved and made more scientifically precise in several spots. Specifically, in 62-63, the authors say that the aged immune system "is also discussed to be more irritable", please change to reflect the common notion that the reaction to infection is dysregulated; in many cases inflammation itself is initially blunted, misdirected, and of different type (e.g. for viruses, the key IFN-I responses are not increased but decreased). In lines 114-117, presumably, the two sentences were supposed to be connected by a comma, although some editing for clarity is probably needed regardless. Line 252, please change "unspecific" to "non-specific". Line 264, please capitalize German. We thank the reviewer for bringing these important points to our attention. We revised our introduction regarding the aged immune response in lines 61-69: “Age-related dysregulation of the immune response is also characterized by inflammaging, defined as the presence of elevated levels of pro-inflammatory cytokines in the absence of an obvious inflammatory trigger (Franceschi et al., 2000; Mogilenko, Shchukina, & Artyomov, 2022). Additionally, immune cells, such as macrophages, exhibit an activated state that alters their response to infection (Canan et al., 2014). In contrast, the immune response of macrophages to infectious challenges has been shown to be initially impaired in aged mice (Boe, Boule, & Kovacs, 2017). Thus aging is a relevant factor impacting the pulmonary immune response.” Sentences were edited to provide more clarity in lines 131-134: “Although G3 Tercko/ko mice with shortened telomeres were used in this study, they were infected at a young age (8 weeks). This approach allowed for the investigation of Terc deletion effects rather than telomere dysfunction.” “Unspecific was changed to “non-specific” in line 282 and “German” was capitalized in line 293 and 558. We appreciate and thank you for your time spent processing this manuscript and look forward to your response. References De la Calle, C., Morata, L., Cobos-Trigueros, N., Martinez, J. A., Cardozo, C., Mensa, J., & Soriano, A. (2016). Staphylococcus aureus bacteremic pneumonia. European Journal of Clinical Microbiology & Infectious Diseases, 35(3), 497-502. https://doi.org/10.1007/s10096-015-2566-8 Dexiu, C., Xianying, L., Yingchun, H., & Jiafu, L. (2022). Advances in CD247. Scand J Immunol, 96(1), e13170. https://doi.org/10.1111/sji.13170 Herrera, E., Samper, E., Martín-Caballero, J., Flores, J. M., Lee, H. W., & Blasco, M. A. (1999). Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. Embo j, 18(11), 2950-2960. https://doi.org/10.1093/emboj/18.11.2950 Hornung, F., Schulz, L., Köse-Vogel, N., Häder, A., Grießhammer, J., Wittschieber, D., Autsch, A., Ehrhardt, C., Mall, G., Löffler, B., & Deinhardt-Emmer, S. (2023). Thoracic adipose tissue contributes to severe virus infection of the lung. International Journal of Obesity, 47(11), 10881099. https://doi.org/10.1038/s41366-023-01362-w Kang, Y., Zhang, H., Zhao, Y., Wang, Y., Wang, W., He, Y., Zhang, W., Zhang, W., Zhu, X., Zhou, Y., Zhang, L., Ju, Z., & Shi, L. (2018). Telomere Dysfunction Disturbs Macrophage Mitochondrial Metabolism and the NLRP3 Inflammasome through the PGC-1α/TNFAIP3 Axis. Cell Reports, 22(13), 3493-3506. https://doi.org/10.1016/j.celrep.2018.02.071 Khan, A. M., Babcock, A. A., Saeed, H., Myhre, C. L., Kassem, M., & Finsen, B. (2015). Telomere dysfunction reduces microglial numbers without fully inducing an aging phenotype. Neurobiology of Aging, 36(6), 2164-2175. https://doi.org/10.1016/j.neurobiolaging.2015.03.008 Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature, 392(6676), 569-574. https://doi.org/10.1038/33345 Liu, H., Yang, Y., Ge, Y., Liu, J., & Zhao, Y. (2019). TERC promotes cellular inflammatory response independent of telomerase. Nucleic Acids Research, 47(15), 8084-8095. https://doi.org/10.1093/nar/gkz584 Matthe, D. M., Thoma, O. M., Sperka, T., Neurath, M. F., & Waldner, M. J. (2022). Telomerase deficiency reflects age-associated changes in CD4+ T cells. Immun Ageing, 19(1), 16. https://doi.org/10.1186/s12979-022-00273-0 Rudolph, K. L., Chang, S., Lee, H. W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell, 96(5), 701-712. https://doi.org/10.1016/s0092-8674(00)80580-2 Tarry-Adkins, J. L., Aiken, C. E., Dearden, L., Fernandez-Twinn, D. S., & Ozanne, S. (2021). Exploring Telomere Dynamics in Aging Male Rat Tissues: Can Tissue-Specific Differences Contribute to Age-Associated Pathologies? Gerontology, 67(2), 233-242. https://doi.org/10.1159/000511608 Wong, L. S. M., Oeseburg, H., de Boer, R. A., van Gilst, W. H., van Veldhuisen, D. J., & van der Harst, P. (2008). Telomere biology in cardiovascular disease: the TERC−/− mouse as a model for heart failure and ageing. Cardiovascular Research, 81(2), 244-252. https://doi.org/10.1093/cvr/cvn337 Wu, S., Ge, Y., Lin, K., Liu, Q., Zhou, H., Hu, Q., Zhao, Y., He, W., & Ju, Z. (2022). Telomerase RNA TERC and the PI3K-AKT pathway form a positive feedback loop to regulate cell proliferation independent of telomerase activity. Nucleic Acids Res, 50(7), 3764-3776. https://doi.org/10.1093/nar/gkac179 Zhang, M. W., Zhao, P., Yung, W. H., Sheng, Y., Ke, Y., & Qian, Z. M. (2018). Tissue iron is negatively correlated with TERC or TERT mRNA expression: A heterochronic parabiosis study in mice. Aging (Albany NY), 10(12), 3834-3850. https://doi.org/10.18632/aging.101676